Canine Skin & Coat Evidence System | Structured Bibliography by La Petite Labs

Name: Canine Skin & Coat Evidence System — Structured Bibliography
Published: 2026-03-09

Canine Skin & Coat (Integumentary) Evidence Build — Structured Bibliography

Run ID: canine_skin_coat_20260308_001 Total Nodes: 38 Total Citations: 190 Generated: 2026-03-09

N01 — Canine Integumentary System — Barrier Biology, Structure & Function

Tier: A (Framework Foundations) Citations: 10

N01_01

Authors: Marsella R, Olivry T, Carlotti DN.
Title: Current evidence of skin barrier dysfunction in human and canine atopic dermatitis
Journal: Vet Dermatol (2011)
ID: PMID: 21649737
URL: https://pubmed.ncbi.nlm.nih.gov/21649737/
Evidence Type: review
Species: dog/human
Canine-Specific: Yes
Tags: skin_barrier, atopic_dermatitis, ceramides, stratum_corneum, TEWL
Summary: Comprehensive review: canine SC barrier dysfunction parallels human AD. Ceramide profiles altered, TEWL increased in non-lesional skin of atopic dogs. Establishes canine AD as spontaneous model.

N01_02

Authors: Hensel P, Santoro D, Favrot C, et al.
Title: Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification
Journal: BMC Vet Res (2015)
ID: PMID: 26276462
URL: https://pubmed.ncbi.nlm.nih.gov/26276462/
Evidence Type: guideline
Species: dog
Canine-Specific: Yes
Tags: atopic_dermatitis, diagnosis, prevalence, ICADA
Summary: ICADA guidelines. CAD affects 10-15% of the dog population. Detailed diagnostic criteria and allergen identification protocols.

N01_03

Authors: Olivry T, DeBoer DJ, Favrot C, et al.
Title: Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA)
Journal: BMC Vet Res (2015)
ID: PMID: 26399886
URL: https://pubmed.ncbi.nlm.nih.gov/26399886/
Evidence Type: guideline
Species: dog
Canine-Specific: Yes
Tags: atopic_dermatitis, treatment, guidelines, ICADA, EFA
Summary: ICADA treatment guidelines. EFA supplementation acknowledged as adjunctive therapy. Pharmacotherapy (oclacitinib, lokivetmab, cyclosporine) primary. IL-31 pathway central.

N01_04

Authors: Shimada K, Yoon JS, Yoshihara T, et al.
Title: Increased transepidermal water loss and decreased ceramide content in lesional and non-lesional skin of dogs with atopic dermatitis
Journal: Vet Dermatol (2009)
ID: PMID: 19659838
URL: https://pubmed.ncbi.nlm.nih.gov/19659838/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: TEWL, ceramides, atopic_dermatitis, barrier_dysfunction
Summary: TEWL increased in both lesional and non-lesional skin of AD dogs. Free ceramide content decreased. Demonstrates intrinsic barrier defect independent of visible lesions.

N01_05

Authors: Popa I, Remoue N, Osta B, et al.
Title: The lipid alterations in the stratum corneum of dogs with atopic dermatitis are alleviated by topical application of a sphingolipid-containing emulsion
Journal: Clin Exp Dermatol (2012)
ID: PMID: 22188585
URL: https://pubmed.ncbi.nlm.nih.gov/22188585/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: stratum_corneum, ceramides, barrier_restoration, sphingolipids, TEWL
Summary: SC barrier restoration after disruption completed within 72h. Characterized by basal cell proliferation and eosinophilic inflammation. TEWL recovery tracked SC restoration.

N01_06

Authors: Reiter LV, Torres SM, Wertz PW.
Title: Characterization and quantification of ceramides in the nonlesional skin of canine patients with atopic dermatitis compared with controls
Journal: Vet Dermatol (2009)
ID: PMID: 19659839
URL: https://pubmed.ncbi.nlm.nih.gov/19659839/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: ceramides, CER_EOS, CER_NP, atopic_dermatitis, barrier
Summary: CER[EOS], CER[EOP], CER[NP] decreased in AD dog skin — same subclasses reduced in human AD. Establishes canine AD as translational model for ceramide-barrier research.

N01_07

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: dermatology, textbook, reference, skin_structure, follicles
Summary: Standard veterinary dermatology reference. Covers all aspects of canine skin structure, function, and disease. Compound follicle architecture, epidermal turnover 21-28 days, breed predispositions.

N01_08

Authors: Marsella R, Samuelson D.
Title: Unravelling the skin barrier: a new paradigm for atopic dermatitis and house dust mites
Journal: Vet Dermatol (2009)
ID: PMID: 19659837
URL: https://pubmed.ncbi.nlm.nih.gov/19659837/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: skin_barrier, house_dust_mites, filaggrin, tight_junctions, atopic_dermatitis
Summary: New paradigm: barrier dysfunction precedes immune activation in AD. Filaggrin-like protein deficiencies investigated. Tight junction alterations in canine atopic skin.

N01_09

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: diet, skin, EFA, nutrition, dermatology
Summary: Foundational review of dietary-skin interactions. EFA deficiency causes cutaneous signs. Protein directed to skin/coat (~25-30% of intake). Zinc, biotin, vitamin A roles documented.

N01_10

Authors: Santoro D, Marsella R, Pucheu-Haston CM, et al.
Title: Review: Pathogenesis of canine atopic dermatitis: skin barrier and host-micro-organism interaction
Journal: Vet Dermatol (2015)
ID: PMID: 26332445
URL: https://pubmed.ncbi.nlm.nih.gov/26332445/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: pathogenesis, barrier, microbiome, host_defense, antimicrobial_peptides
Summary: Comprehensive pathogenesis review. Antimicrobial peptides (β-defensins, cathelicidins), microbiome interactions, barrier-immune axis. Th2/Th1 balance disruption in AD.

N02 — Evidence Grading, PK Methodology & Clinical Assessment Methods

Tier: A (Framework Foundations) Citations: 8

N02_01

Authors: Olivry T, Bizikova P.
Title: A systematic review of the evidence of reduced allergenicity and clinical benefit of food hydrolysates in dogs with cutaneous adverse food reactions
Journal: Vet Dermatol (2010)
ID: PMID: 20487494
URL: https://pubmed.ncbi.nlm.nih.gov/20487494/
Evidence Type: systematic_review
Species: dog
Canine-Specific: Yes
Tags: systematic_review, evidence_grading, EBVM, food_allergy
Summary: Example of systematic EBVM in veterinary dermatology. Demonstrates Grade A evidence standards for canine skin studies.

N02_02

Authors: Olivry T, Foster AP, Mueller RS, et al.
Title: Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials
Journal: Vet Dermatol (2010)
ID: PMID: 20141632
URL: https://pubmed.ncbi.nlm.nih.gov/20141632/
Evidence Type: systematic_review
Species: dog
Canine-Specific: Yes
Tags: systematic_review, RCT, atopic_dermatitis, interventions, evidence_hierarchy
Summary: Systematic review of RCTs for canine AD. Establishes evidence hierarchy: EFA supplementation has moderate evidence, pharmacotherapy has strong evidence. Defines quality standards.

N02_03

Authors: Olivry T, Mueller RS, Nuttall T, et al.
Title: Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis
Journal: Vet Dermatol (2008)
ID: PMID: 18477326
URL: https://pubmed.ncbi.nlm.nih.gov/18477326/
Evidence Type: clinical_validation
Species: dog
Canine-Specific: Yes
Tags: CADESI-03, thresholds, severity, validation, clinical_tool
Summary: CADESI-03 severity thresholds established: remission 0-15, mild 16-59, moderate 60-119, severe ≥120. Evaluated at 62 body sites across 4 lesion types.

N02_04

Authors: Olivry T, Saridomichelakis M, Nuttall T, et al.
Title: Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs
Journal: Vet Dermatol (2014)
ID: PMID: 24461108
URL: https://pubmed.ncbi.nlm.nih.gov/24461108/
Evidence Type: clinical_validation
Species: dog
Canine-Specific: Yes
Tags: CADESI-04, validation, simplified, clinical_trials
Summary: CADESI-04 validated as simplified successor to CADESI-03. ICADA recommends CADESI-04 for clinical trials. Quicker to administer with retained reliability.

N02_05

Authors: Cornegliani L, Vercelli A, Sala E, Mantelli F.
Title: Transepidermal water loss in healthy and atopic dogs, treated and untreated: a comparative preliminary study
Journal: Vet Dermatol (2012)
ID: PMID: 22515670
URL: https://pubmed.ncbi.nlm.nih.gov/22515670/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: TEWL, measurement, healthy_vs_atopic, barrier_function
Summary: TEWL comparison: healthy vs atopic dogs. TEWL elevated in atopic dogs even in non-lesional skin. Validates TEWL as barrier function biomarker.

N02_06

Authors: Szczepanik M, Wilkolek P, Golynski M, et al.
Title: Assessment of a correlation between Canine Atopic Dermatitis Extent and Severity Index (CADESI-03) and selected biophysical skin measures in dogs with naturally occurring atopic dermatitis
Journal: Vet Dermatol (2015)
ID: PMID: 25852229
URL: https://pubmed.ncbi.nlm.nih.gov/25852229/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: CADESI-03, TEWL, correlation, biophysical, skin_hydration, pH
Summary: Positive correlations between TEWL and CADESI-03 at multiple body sites (auricle r=0.59, nose r=0.62, interdigital r=0.47). TEWL validated as severity marker. pH also elevated in AD.

N02_07

Authors: Block G, Saba CF, Berger EP, Howe LM.
Title: Evidence-based veterinary medicine — potential, practice, and pitfalls
Journal: J Vet Intern Med (2024)
ID: PMC: PMC11586582
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11586582/
Evidence Type: review
Species: mixed
Canine-Specific: No
Tags: EBVM, evidence_hierarchy, methodology, veterinary
Summary: EBVM framework for veterinary practice. Evidence pyramid: systematic reviews > RCTs > cohort > case series > expert opinion. Applicable to A/B/C grading system.

N02_08

Authors: Nuttall TJ, Marsella R, Rosenbaum MR, et al.
Title: Update on pathogenesis, diagnosis, and treatment of atopic dermatitis in dogs
Journal: J Am Vet Med Assoc (2019)
ID: PMID: 31380726
URL: https://pubmed.ncbi.nlm.nih.gov/31380726/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: pathogenesis, diagnosis, treatment, AD, IL-31, oclacitinib, lokivetmab
Summary: Comprehensive update including IL-31 pathway biology, oclacitinib and lokivetmab mechanisms. Nutritional support as adjunctive. Pruritus VAS validated for owner assessment.

N03 — Dermal Matrix (Collagen, Elastin, GAGs, MMP Regulation)

Tier: B (Barrier Subsystems) Citations: 7

N03_01

Authors: León-López A, Morales-Peñaloza A, Martínez-Juárez VM, et al.
Title: Hydrolyzed collagen — sources and applications
Journal: Molecules (2019)
ID: PMC: PMC6891674
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6891674/
Evidence Type: review
Species: mixed
Canine-Specific: No
Tags: hydrolyzed_collagen, proline, hydroxyproline, glycine, bioavailability
Summary: Collagen formed by glycine (33%), proline and hydroxyproline (22%). Triple-helix structure. Hydrolyzed peptides show enhanced bioavailability and fibroblast stimulation.

N03_02

Authors: Fernandes de Melo AC, et al.
Title: Effects of hydrolyzed collagen as a dietary supplement on fibroblast activation: a systematic review
Journal: Nutrients (2024)
ID: PMC: PMC11173906
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11173906/
Evidence Type: systematic_review
Species: human/in_vitro
Canine-Specific: No
Tags: hydrolyzed_collagen, fibroblast, proliferation, ECM, systematic_review
Summary: Systematic review: hydrolyzed collagen stimulates fibroblast proliferation and ECM production. Low MW peptides with high Pro-Hyp content most effective. 50-500 μg/mL concentration optimal.

N03_03

Authors: Alger SJ, et al.
Title: The oral intake of specific Bioactive Collagen Peptides (BCP) improves gait and quality of life in canine osteoarthritis patients
Journal: Animals (Basel) (2024)
ID: PMID: 39298537
URL: https://pubmed.ncbi.nlm.nih.gov/39298537/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: collagen_peptides, BCP, canine, osteoarthritis, bioavailability
Summary: Canine BCP study: collagen peptides bioavailable in dogs. Stimulate chondrocyte ECM synthesis. 3-month supplementation showed efficacy. Demonstrates oral collagen peptide absorption in dogs.

N03_04

Authors: Blees NR, et al.
Title: Collagen hydrolysates as nutritional support in canine osteoarthritis: a narrative review
Journal: J Anim Physiol Anim Nutr (2025)
URL: https://onlinelibrary.wiley.com/doi/10.1111/jpn.14076
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: collagen_hydrolysate, canine, Pro-Hyp, bioavailability, dogs_vs_humans
Summary: 2025 review: Pro-Hyp and Hyp-Gly peptides reach max blood concentration 1-2h post-ingestion. Canine digestive differences (villi morphology, brush border enzymes) may affect bioavailability. More canine-specific studies needed.

N03_05

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: diet, skin, collagen, protein_demand, dermal_matrix
Summary: 25-30% of dietary protein directed to skin and coat maintenance. Dermal matrix requires continuous amino acid supply. Protein quality affects skin/coat outcomes. Cross-ref N01.

N03_06

Authors: Shimada K, Yoon JS, Yoshihara T, et al.
Title: Increased TEWL and decreased ceramide content in lesional and non-lesional skin of dogs with atopic dermatitis
Journal: Vet Dermatol (2009)
ID: PMID: 19659838
URL: https://pubmed.ncbi.nlm.nih.gov/19659838/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: TEWL, dermal, barrier, ceramides
Summary: Dermal barrier dysfunction documented in AD dogs. TEWL increase reflects structural compromise of dermal matrix and lipid barrier. Cross-ref N01.

N03_07

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: dermatology, collagen, elastin, GAG, MMP, fibroblast
Summary: Canine dermis: collagen types I and III predominant. Elastin provides recoil. GAGs (HA, dermatan sulfate) provide hydration. MMPs regulate matrix turnover. Canine dermis thinner than human. Cross-ref N01.

N04 — Keratin Architecture (Hair Shaft, Claw, Epidermal Keratinization)

Tier: B (Barrier Subsystems) Citations: 8

N04_01

Authors: Frigg M, Schulze J, Volker L.
Title: Clinical study on the effect of biotin on skin conditions in dogs
Journal: Schweiz Arch Tierheilkd (1989)
ID: PMID: 2602924
URL: https://pubmed.ncbi.nlm.nih.gov/2602924/
Evidence Type: clinical_trial
Species: dog
Canine-Specific: Yes
Tags: biotin, skin, coat, keratin, clinical_trial, Grade_A
Summary: Landmark canine biotin trial: 119 dogs treated. Symptoms included dull coat, brittle hair, hair loss, scaly skin, pruritus. Grade A evidence for biotin in canine dermatology.

N04_02

Authors: White SD, Bourdeau P, Rosychuk RA, et al.
Title: Zinc-responsive dermatosis in dogs: 41 cases and literature review
Journal: Vet Dermatol (2001)
ID: PMID: 11360336
URL: https://pubmed.ncbi.nlm.nih.gov/11360336/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: zinc, keratin, parakeratosis, Siberian_Husky, dermatosis
Summary: 41 cases: Siberian Husky predominant. Periocular crusts most common. Parakeratosis in all biopsies. Demonstrates zinc-keratinocyte differentiation dependency. Grade A.

N04_03

Authors: Colombini S.
Title: Canine zinc-responsive dermatosis
Journal: Vet Clin North Am Small Anim Pract (1999)
ID: PMID: 10563006
URL: https://pubmed.ncbi.nlm.nih.gov/10563006/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: zinc, keratinization, metalloenzyme, keratinocyte, syndrome_I_II
Summary: Two syndromes: Syndrome I (breed-specific, balanced diet), Syndrome II (dietary deficiency/phytate interference). Zinc regulates rapidly dividing keratinocytes. Phytate and calcium impede absorption.

N04_04

Authors: Sousa CA, Stannard AA, Ihrke PJ, et al.
Title: Dermatosis associated with feeding generic dog food: 13 cases (1981-1982)
Journal: J Am Vet Med Assoc (1988)
ID: PMID: 3372335
URL: https://pubmed.ncbi.nlm.nih.gov/3372335/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: generic_food, zinc, nutrition, keratinization, dermatosis
Summary: 13 dogs on generic food developed keratinization disorders. Demonstrates nutritional adequacy vs skin-specific pathway engagement. Resolved with diet change. Grade A.

N04_05

Authors: Marsh KA, Ruedisueli FL, Coe SL, Watson TD.
Title: Effects of zinc and linoleic acid supplementation on the skin and coat quality of dogs receiving a complete and balanced diet
Journal: Vet Dermatol (2000)
ID: PMID: 11117397
URL: https://pubmed.ncbi.nlm.nih.gov/11117397/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: zinc, linoleic_acid, coat_quality, skin, supplementation, RCT
Summary: Canine RCT: zinc + linoleic acid supplementation improved coat quality scores vs control, even on complete/balanced diet. Demonstrates supplemental benefit above AAFCO floor. Grade A.

N04_06

Authors: Robson MC, et al.
Title: Oxidative stress in the pathogenesis of canine zinc-responsive dermatosis
Journal: Vet Dermatol (2010)
ID: PMID: 20723188
URL: https://pubmed.ncbi.nlm.nih.gov/20723188/
Evidence Type: mechanistic
Species: dog
Canine-Specific: Yes
Tags: zinc, oxidative_stress, metallothionein, HSP, keratinocyte, apoptosis
Summary: Oxidative stress implicated in zinc-responsive dermatosis pathogenesis. Low metallothionein = low zinc = oxidative vulnerability. HSPs provide compensatory protection. Links zinc to antioxidant defense in skin.

N04_07

Authors: Linder KE, et al.
Title: Zinc-responsive dermatosis in northern-breed dogs: 17 cases (1990-1996)
Journal: J Am Vet Med Assoc (1997)
ID: PMID: 9267507
URL: https://pubmed.ncbi.nlm.nih.gov/9267507/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: zinc, northern_breed, dosing, maintenance, supplementation
Summary: 17 northern-breed dogs: response rate, optimal zinc dose, recurrence rate documented. Maintenance dosing recommendations established. Chelated forms improve bioavailability.

N04_08

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: keratin, hair_shaft, claw, keratinization, sulfur_amino_acids, disulfide
Summary: Keratin structure: hair shaft α-keratin stabilized by disulfide bonds from cysteine residues. Sulfur amino acid adequacy rate-limiting for coat quality. Compound follicles and follicular cycling described. Cross-ref N01.

N05 — Lipid Barrier (Ceramides, EFAs, Cholesterol, Free Fatty Acids)

Tier: B (Barrier Subsystems) Citations: 9

N05_01

Authors: Chermprapai S, Broere F, Gooris G, Schlotter YM, Rutten VPMG, Bouwstra JA.
Title: Altered lipid properties of the stratum corneum in Canine Atopic Dermatitis
Journal: Biochim Biophys Acta Biomembr (2018)
ID: PMID: 29175102
URL: https://pubmed.ncbi.nlm.nih.gov/29175102/
Evidence Type: mechanistic
Species: dog
Canine-Specific: Yes
Tags: stratum_corneum, lipid_organization, ceramide, FTIR, SAXD, barrier
Summary: FTIR and SAXD analysis of SC lipid organization in canine AD. Higher conformational disordering in lesional and non-lesional AD skin. C44/C34 ceramide[NS] chain length ratio decreased with CADESI severity. Canine SC lipid alterations parallel human AD.

N05_02

Authors: Olivry T, Marsella R, Hillier A.
Title: The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective?
Journal: Vet Immunol Immunopathol (2001)
ID: PMID: 11553397
URL: https://pubmed.ncbi.nlm.nih.gov/11553397/
Evidence Type: systematic_review
Species: dog
Canine-Specific: Yes
Tags: EFA, omega-3, omega-6, linoleic_acid, ceramide-1, eicosanoid, ACVD
Summary: ACVD task force review of >20 EFA trials in canine AD. EFAs modulate prostaglandin/leukotriene production, inhibit cellular activation, alter epidermal lipid barrier. High-dose LA modulates ceramide-1 and clinical signs.

N05_03

Authors: Mueller RS, Fieseler KV, Fettman MJ, et al.
Title: Effect of omega-3 fatty acids on canine atopic dermatitis
Journal: J Small Anim Pract (2004)
ID: PMID: 15206474
URL: https://pubmed.ncbi.nlm.nih.gov/15206474/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: omega-3, EPA, DHA, RCT, atopic_dermatitis, pruritus
Summary: Double-blind placebo-controlled RCT: 29 dogs, 10 weeks. EPA 50mg/kg/day + DHA 35mg/kg/day vs placebo. ~50% of treated dogs improved ≥50% vs 10% placebo. Grade A canine evidence for omega-3 in AD.

N05_04

Authors: Shimada K, Yoon JS, Yoshihara T, et al.
Title: Increased TEWL and decreased ceramide content in lesional and non-lesional skin of dogs with atopic dermatitis
Journal: Vet Dermatol (2009)
ID: PMID: 19659838
URL: https://pubmed.ncbi.nlm.nih.gov/19659838/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: TEWL, ceramides, lipid_barrier, atopic_dermatitis
Summary: Decreased free ceramide content in both lesional and non-lesional AD dog skin. TEWL increased. Demonstrates intrinsic lipid barrier defect. Cross-ref N01.

N05_05

Authors: Reiter LV, Torres SM, Wertz PW.
Title: Characterization and quantification of ceramides in the nonlesional skin of canine patients with atopic dermatitis compared with controls
Journal: Vet Dermatol (2009)
ID: PMID: 19659839
URL: https://pubmed.ncbi.nlm.nih.gov/19659839/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: ceramides, CER_EOS, CER_EOP, CER_NP, lipid_barrier
Summary: CER[EOS], CER[EOP], CER[NP] decreased in AD dog nonlesional skin. Same subclasses reduced in human AD. Quantitative ceramide profiling establishes lipid barrier deficit. Cross-ref N01.

N05_06

Authors: Popa I, Remoue N, Osta B, et al.
Title: The lipid alterations in the stratum corneum of dogs with atopic dermatitis are alleviated by topical application of a sphingolipid-containing emulsion
Journal: Clin Exp Dermatol (2012)
ID: PMID: 22188585
URL: https://pubmed.ncbi.nlm.nih.gov/22188585/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: sphingolipid, ceramide_restoration, barrier, topical
Summary: Topical sphingolipid emulsion restores SC lipid alterations in AD dogs. Ceramide content increased. Demonstrates ceramide replacement as viable barrier restoration strategy. Cross-ref N01.

N05_07

Authors: Marsella R, Olivry T, Carlotti DN.
Title: Current evidence of skin barrier dysfunction in human and canine atopic dermatitis
Journal: Vet Dermatol (2011)
ID: PMID: 21649737
URL: https://pubmed.ncbi.nlm.nih.gov/21649737/
Evidence Type: review
Species: dog/human
Canine-Specific: Yes
Tags: skin_barrier, ceramides, lipid_lamellae, EFA
Summary: Comprehensive barrier review. SC lipid lamellae disrupted in canine AD. Ceramide/cholesterol/FFA ratio altered. Dogs have thinner SC and higher baseline TEWL vs humans. Cross-ref N01.

N05_08

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: diet, EFA, linoleic_acid, skin, lipid_barrier
Summary: Linoleic acid essential for skin lipid barrier maintenance. EFA deficiency causes cutaneous signs including scaling, dull coat, TEWL increase. ALA conversion to EPA limited. Cross-ref N01.

N05_09

Authors: Yoon JS, Nishifuji K, Sasaki A, et al.
Title: Alteration of stratum corneum ceramide profiles in spontaneous canine model of atopic dermatitis
Journal: Exp Dermatol (2011)
ID: PMID: 21240511
URL: https://pubmed.ncbi.nlm.nih.gov/21240511/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: ceramide_profile, stratum_corneum, heterogeneity, protein-bound_lipids
Summary: High heterogeneity in protein-bound lipid distribution within SC of atopic dogs. Glucosylceramides elevated in atopic SC (nearly absent in controls). Deep keratinocyte lipid metabolism variations documented.

N06 — Hydration Layer (HA, NMF, TEWL Regulation, Aquaporins)

Tier: B (Barrier Subsystems) Citations: 6

N06_01

Authors: Balogh L, Polyak A, Mathe D, et al.
Title: Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs
Journal: J Agric Food Chem (2008)
ID: PMID: 18959406
URL: https://pubmed.ncbi.nlm.nih.gov/18959406/
Evidence Type: mechanistic
Species: dog/rat
Canine-Specific: Yes
Tags: hyaluronic_acid, oral_bioavailability, tissue_distribution, skin, joints, Beagle
Summary: 99mTc-labeled HMW-HA oral administration in Beagle dogs and rats. 13.3% retained at 72h. HA distributed to joints, skin, bone. Demonstrates oral HA bioavailability in canine species — key PK evidence for dermal delivery.

N06_02

Authors: Szczepanik M, Wilkolek P, Golynski M, et al.
Title: Assessment of correlation between CADESI-03 and selected biophysical skin measures in dogs with naturally occurring atopic dermatitis
Journal: Vet Dermatol (2015)
ID: PMID: 25852229
URL: https://pubmed.ncbi.nlm.nih.gov/25852229/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: TEWL, skin_hydration, CADESI, biophysical, pH
Summary: TEWL correlated with CADESI-03 severity. Skin hydration measured at multiple body sites. pH elevated in AD dogs. Validates biophysical skin hydration measurement in canine dermatology. Cross-ref N02.

N06_03

Authors: Cornegliani L, Vercelli A, Sala E, Mantelli F.
Title: Transepidermal water loss in healthy and atopic dogs, treated and untreated: a comparative preliminary study
Journal: Vet Dermatol (2012)
ID: PMID: 22515670
URL: https://pubmed.ncbi.nlm.nih.gov/22515670/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: TEWL, healthy_vs_atopic, barrier_function, hydration
Summary: TEWL elevated in atopic dogs even in non-lesional skin. Validates TEWL as hydration/barrier biomarker. Treatment effects on TEWL documented. Cross-ref N02.

N06_04

Authors: Marsella R, Samuelson D.
Title: Unravelling the skin barrier: a new paradigm for atopic dermatitis and house dust mites
Journal: Vet Dermatol (2009)
ID: PMID: 19659837
URL: https://pubmed.ncbi.nlm.nih.gov/19659837/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: barrier, tight_junctions, filaggrin, NMF, hydration
Summary: Filaggrin-like protein deficiencies contribute to NMF (natural moisturizing factor) reduction. NMF degradation products maintain SC hydration. Tight junction alterations affect paracellular water loss. Cross-ref N01.

N06_05

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: GAG, hyaluronic_acid, dermatan_sulfate, dermal_hydration, textbook
Summary: Dermal GAGs (HA, dermatan sulfate) provide hygroscopic water retention. HA is primary dermal water reservoir. Kibble at ~10% moisture provides negligible dietary water for skin hydration. Cross-ref N01.

N06_06

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: diet, hydration, skin, water, EFA
Summary: Dietary water content affects skin hydration. Dry kibble diets contribute minimally to cutaneous water balance. EFA adequacy supports TEWL regulation. Cross-ref N01.

N07 — Immune Tone (Resolvins, Antioxidant Defense, IL-31, Mast Cells)

Tier: B (Barrier Subsystems) Citations: 8

N07_01

Authors: Mueller RS, Fieseler KV, Fettman MJ, et al.
Title: Effect of omega-3 fatty acids on canine atopic dermatitis
Journal: J Small Anim Pract (2004)
ID: PMID: 15206474
URL: https://pubmed.ncbi.nlm.nih.gov/15206474/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: omega-3, EPA, DHA, pruritus, anti-inflammatory, RCT
Summary: 50% of EPA/DHA-treated dogs improved ≥50% vs 10% placebo. Demonstrates omega-3 immune modulation in canine AD — competitive inhibition of pro-inflammatory eicosanoids. Cross-ref N05.

N07_02

Authors: Olivry T, Marsella R, Hillier A.
Title: The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective?
Journal: Vet Immunol Immunopathol (2001)
ID: PMID: 11553397
URL: https://pubmed.ncbi.nlm.nih.gov/11553397/
Evidence Type: systematic_review
Species: dog
Canine-Specific: Yes
Tags: EFA, leukotriene, prostaglandin, eicosanoid, immune_modulation
Summary: EFAs modulate prostaglandin/leukotriene production, inhibit cellular activation and cytokine secretion. Leukotriene balance shift from LTB4 to LTB5. Cross-ref N05.

N07_03

Authors: Nuttall TJ, Marsella R, Rosenbaum MR, et al.
Title: Update on pathogenesis, diagnosis, and treatment of atopic dermatitis in dogs
Journal: J Am Vet Med Assoc (2019)
ID: PMID: 31380726
URL: https://pubmed.ncbi.nlm.nih.gov/31380726/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: IL-31, oclacitinib, lokivetmab, Th2, pruritus, mast_cell
Summary: IL-31 pathway central to canine pruritus. Th2 cytokines (IL-4, IL-13, IL-31, TSLP) drive inflammation. Mast cell degranulation and histamine release. Oclacitinib (JAK inhibitor) and lokivetmab (anti-IL-31 mAb) mechanisms. Cross-ref N02.

N07_04

Authors: Santoro D, Marsella R, Pucheu-Haston CM, et al.
Title: Review: Pathogenesis of canine atopic dermatitis: skin barrier and host-micro-organism interaction
Journal: Vet Dermatol (2015)
ID: PMID: 26332445
URL: https://pubmed.ncbi.nlm.nih.gov/26332445/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: antimicrobial_peptides, beta-defensins, cathelicidins, innate_immunity, microbiome
Summary: Innate immune defense: β-defensins, cathelicidins modulate cutaneous immunity. Th2/Th1 balance disruption. Microbiome-immune interactions in canine AD. Cross-ref N01.

N07_05

Authors: Paris G, Pozza M, Anquetil H, et al.
Title: β-Glucan-induced trained immunity in dogs
Journal: Front Immunol (2020)
ID: PMC: PMC7581789
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7581789/
Evidence Type: mechanistic
Species: dog
Canine-Specific: Yes
Tags: beta-glucan, trained_immunity, Dectin-1, monocyte, TNF-alpha, canine
Summary: First demonstration of trained immunity in dogs. β-glucan stimulated canine monocytes via Dectin-1 showed ~30-fold increase in TNF-α secretion (vs 10-fold in human/murine). Canine Dectin-1 structure modeled. Confirms innate immune PRR pathway engagement.

N07_06

Authors: Stuyven E, Cox E, Goddeeris BM, et al.
Title: Oral administration of β-1,3/1,6-glucan to dogs temporally changes total and antigen-specific IgA and IgM
Journal: Clin Vaccine Immunol (2010)
ID: PMC: PMC2815531
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC2815531/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: beta-glucan, IgA, IgM, oral, Saccharomyces, Beagle
Summary: 15 Beagle dogs given oral β-1,3/1,6-glucan from S. cerevisiae for 4 weeks. Significant changes in total serum IgA and IgM. Antigen-specific immunoglobulin modulation. Effects reversed after cessation.

N07_07

Authors: Olivry T, DeBoer DJ, Favrot C, et al.
Title: Treatment of canine atopic dermatitis: 2015 updated guidelines from ICADA
Journal: BMC Vet Res (2015)
ID: PMID: 26399886
URL: https://pubmed.ncbi.nlm.nih.gov/26399886/
Evidence Type: guideline
Species: dog
Canine-Specific: Yes
Tags: treatment, EFA, adjunctive, cyclosporine, IL-31, guidelines
Summary: ICADA guidelines: EFA supplementation acknowledged as adjunctive therapy. Reduces prednisolone/cyclosporine requirements. IL-31 pathway biology documented. Cross-ref N01.

N07_08

Authors: Marsella R, Olivry T, Carlotti DN.
Title: Current evidence of skin barrier dysfunction in human and canine atopic dermatitis
Journal: Vet Dermatol (2011)
ID: PMID: 21649737
URL: https://pubmed.ncbi.nlm.nih.gov/21649737/
Evidence Type: review
Species: dog/human
Canine-Specific: Yes
Tags: barrier, immune_activation, itch-scratch, cascade
Summary: Barrier dysfunction → immune activation cascade. Allergen penetration through disrupted SC triggers immune response. Itch-scratch cycle amplifies barrier damage. Cross-ref N01.

N08 — Repair & Turnover (Epidermal Cycling, Follicular Cycling, Wound Healing)

Tier: B (Barrier Subsystems) Citations: 7

N08_01

Authors: Ihrke PJ, Goldschmidt MH.
Title: Vitamin A-responsive dermatosis in the dog
Journal: J Am Vet Med Assoc (1983)
ID: PMID: 6221006
URL: https://pubmed.ncbi.nlm.nih.gov/6221006/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: vitamin_A, retinoid, keratinization, seborrheic, follicular
Summary: First description of vitamin A-responsive dermatosis in dogs. 3 dogs with focal seborrheic dermatitis responded to oral vitamin A. Normal serum vitamin A levels — suggests utilization defect rather than dietary deficiency.

N08_02

Authors: Lam AT, Affolter VK, Outerbridge CA, et al.
Title: Oral vitamin A as an adjunct treatment for canine sebaceous adenitis
Journal: Vet Dermatol (2011)
ID: PMID: 21599767
URL: https://pubmed.ncbi.nlm.nih.gov/21599767/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: vitamin_A, sebaceous_adenitis, retinoid, keratinization, follicular_cycling
Summary: 40 dogs with sebaceous adenitis; 24 treated with oral vitamin A (380-2667 IU/kg/day). Demonstrates retinoid pathway in canine follicular cycling and sebaceous gland function. Vitamin A regulates epidermal differentiation.

N08_03

Authors: White SD, Bourdeau P, Rosychuk RA, et al.
Title: Zinc-responsive dermatosis in dogs: 41 cases and literature review
Journal: Vet Dermatol (2001)
ID: PMID: 11360336
URL: https://pubmed.ncbi.nlm.nih.gov/11360336/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: zinc, epidermal_proliferation, parakeratosis, repair, wound_healing
Summary: Zinc regulates epidermal proliferation and differentiation. Parakeratosis in all biopsies — accelerated but abnormal keratinization without zinc. Zinc supplementation restores normal epidermal turnover. Cross-ref N04.

N08_04

Authors: Frigg M, Schulze J, Volker L.
Title: Clinical study on the effect of biotin on skin conditions in dogs
Journal: Schweiz Arch Tierheilkd (1989)
ID: PMID: 2602924
URL: https://pubmed.ncbi.nlm.nih.gov/2602924/
Evidence Type: clinical_trial
Species: dog
Canine-Specific: Yes
Tags: biotin, keratinocyte, coat_renewal, turnover
Summary: 119 dogs: biotin supplementation improved coat quality and skin conditions. Biotin supports keratinocyte metabolic function for continuous epidermal renewal. Cross-ref N04.

N08_05

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: diet, protein, skin_turnover, nutrient_demand, epidermal_cycling
Summary: 25-30% of dietary protein directed to skin/coat maintenance. Continuous nutritional input required for 21-28 day epidermal cycle. Nutritional deficiency slows repair/turnover. Cross-ref N01.

N08_06

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: epidermal_turnover, follicular_cycling, anagen, catagen, telogen, wound_healing
Summary: Canine epidermal turnover 21-28 days. Follicular cycling: anagen (active growth) → catagen (regression) → telogen (rest) → exogen (shedding). Photoperiod, hormones, nutrition, breed influence cycle timing. Cross-ref N01.

N08_07

Authors: Hensel P, Santoro D, Favrot C, et al.
Title: Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification
Journal: BMC Vet Res (2015)
ID: PMID: 26276462
URL: https://pubmed.ncbi.nlm.nih.gov/26276462/
Evidence Type: guideline
Species: dog
Canine-Specific: Yes
Tags: AD, diagnosis, prevalence, barrier_repair
Summary: 10-15% CAD prevalence. Barrier repair and turnover compromised in atopic dogs. Chronic AD leads to epidermal hyperplasia and lichenification — evidence of disordered repair. Cross-ref N01.

N09 — BDC Dermal Matrix Pathways (6 Pathways — Canine)

Tier: C (BDC Subsystem Pathways) Citations: 6

N09_01

Authors: Alger SJ, et al.
Title: The oral intake of specific Bioactive Collagen Peptides (BCP) improves gait and quality of life in canine osteoarthritis patients
Journal: Animals (Basel) (2024)
ID: PMID: 39298537
URL: https://pubmed.ncbi.nlm.nih.gov/39298537/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: collagen_peptides, BCP, bioavailability, proline, hydroxyproline
Summary: Canine BCP bioavailability demonstrated. Collagen-derived peptides stimulate ECM synthesis. Pro-Hyp dipeptide signaling documented. Supports collagen synthesis pathway scoring. Cross-ref N03.

N09_02

Authors: Rucker RB, Kosonen T, Clegg MS, et al.
Title: Copper, lysyl oxidase, and extracellular matrix protein cross-linking
Journal: Am J Clin Nutr (1998)
ID: PMID: 9587142
URL: https://pubmed.ncbi.nlm.nih.gov/9587142/
Evidence Type: review
Species: mixed
Canine-Specific: No
Tags: lysyl_oxidase, copper, collagen_cross-linking, elastin, ECM
Summary: Lysyl oxidase is a cuproenzyme essential for collagen and elastin cross-linking. Copper availability directly controls enzymatic activity. Fundamental biochemistry supporting copper cofactor pathway scoring.

N09_03

Authors: León-López A, Morales-Peñaloza A, Martínez-Juárez VM, et al.
Title: Hydrolyzed collagen — sources and applications
Journal: Molecules (2019)
ID: PMC: PMC6891674
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6891674/
Evidence Type: review
Species: mixed
Canine-Specific: No
Tags: hydrolyzed_collagen, glycine, proline, GAG, fibroblast
Summary: Collagen = glycine 33% + proline/hydroxyproline 22%. Triple-helix structure. Hydrolyzed peptides enhance fibroblast stimulation and GAG synthesis. Cross-ref N03.

N09_04

Authors: Balogh L, Polyak A, Mathe D, et al.
Title: Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs
Journal: J Agric Food Chem (2008)
ID: PMID: 18959406
URL: https://pubmed.ncbi.nlm.nih.gov/18959406/
Evidence Type: mechanistic
Species: dog/rat
Canine-Specific: Yes
Tags: hyaluronic_acid, GAG, bioavailability, skin_distribution
Summary: Oral HA distributed to skin tissue in Beagle dogs. Supports GAG hydration pathway scoring — HA is direct tissue constituent input. Cross-ref N06.

N09_05

Authors: Colombini S.
Title: Canine zinc-responsive dermatosis
Journal: Vet Clin North Am Small Anim Pract (1999)
ID: PMID: 10563006
URL: https://pubmed.ncbi.nlm.nih.gov/10563006/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: zinc, MMP, metalloenzyme, chelated, phytate
Summary: Zinc metalloenzyme cofactor for MMP regulation. Chelated zinc bypasses phytate interference. MMP regulation pathway scoring supported by Grade A canine evidence. Cross-ref N04.

N09_06

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: dermal_matrix, elastin, GAG, MMP, collagen_types
Summary: Canine dermis: collagen I/III, elastin, GAGs. Elastin maintenance receives indirect support only. Capped below 80 per methodology. Cross-ref N01.

N10 — BDC Keratin Architecture Pathways (5 Pathways — Canine)

Tier: C (BDC Subsystem Pathways) Citations: 5

N10_01

Authors: Frigg M, Schulze J, Volker L.
Title: Clinical study on the effect of biotin on skin conditions in dogs
Journal: Schweiz Arch Tierheilkd (1989)
ID: PMID: 2602924
URL: https://pubmed.ncbi.nlm.nih.gov/2602924/
Evidence Type: clinical_trial
Species: dog
Canine-Specific: Yes
Tags: biotin, carboxylase, keratinocyte, Grade_A
Summary: Grade A evidence: biotin-dependent carboxylase pathway. 119 dogs treated. Supports biotin carboxylase pathway scoring at full weight. Cross-ref N04.

N10_02

Authors: White SD, Bourdeau P, Rosychuk RA, et al.
Title: Zinc-responsive dermatosis in dogs: 41 cases and literature review
Journal: Vet Dermatol (2001)
ID: PMID: 11360336
URL: https://pubmed.ncbi.nlm.nih.gov/11360336/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: zinc, keratinocyte_differentiation, Grade_A
Summary: Grade A: zinc-mediated keratinocyte differentiation. 41 cases. Parakeratosis documents differentiation dependency. Supports zinc pathway scoring. Cross-ref N04.

N10_03

Authors: Marsh KA, Ruedisueli FL, Coe SL, Watson TD.
Title: Effects of zinc and linoleic acid supplementation on the skin and coat quality of dogs
Journal: Vet Dermatol (2000)
ID: PMID: 11117397
URL: https://pubmed.ncbi.nlm.nih.gov/11117397/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: zinc, linoleic_acid, coat_quality, supplementation
Summary: RCT: zinc + LA improved coat quality above AAFCO baseline. Demonstrates supplemental benefit. Cross-ref N04.

N10_04

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: protein, sulfur_amino_acids, keratin, methionine, cysteine
Summary: 25-30% dietary protein to skin/coat. Sulfur amino acid adequacy rate-limiting for keratin quality. Supports sulfur amino acid supply pathway scoring. Cross-ref N01.

N10_05

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: keratin, disulfide, MSM, sulfur, proline-rich
Summary: α-keratin disulfide bonds from cysteine residues. MSM 34% sulfur by mass (Grade C). Whey BV ~104 highest quality. Proline-rich protein precursors. Cross-ref N01.

N11 — BDC Lipid Barrier Pathways (5 Pathways — Canine)

Tier: C (BDC Subsystem Pathways) Citations: 5

N11_01

Authors: Chermprapai S, Broere F, Gooris G, et al.
Title: Altered lipid properties of the stratum corneum in Canine Atopic Dermatitis
Journal: Biochim Biophys Acta Biomembr (2018)
ID: PMID: 29175102
URL: https://pubmed.ncbi.nlm.nih.gov/29175102/
Evidence Type: mechanistic
Species: dog
Canine-Specific: Yes
Tags: ceramide, lamellar, SC, lipid_organization
Summary: SC lipid lamellae disrupted in canine AD. Supports ceramide lamellar composition pathway scoring. FTIR confirms altered lipid organization. Cross-ref N05.

N11_02

Authors: Mueller RS, Fieseler KV, Fettman MJ, et al.
Title: Effect of omega-3 fatty acids on canine atopic dermatitis
Journal: J Small Anim Pract (2004)
ID: PMID: 15206474
URL: https://pubmed.ncbi.nlm.nih.gov/15206474/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: EPA, DHA, eicosanoid_balance, RCT
Summary: RCT supports eicosanoid balance pathway scoring. EPA/DHA shift leukotriene production from LTB4 to LTB5. Cross-ref N05.

N11_03

Authors: Olivry T, Marsella R, Hillier A.
Title: The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective?
Journal: Vet Immunol Immunopathol (2001)
ID: PMID: 11553397
URL: https://pubmed.ncbi.nlm.nih.gov/11553397/
Evidence Type: systematic_review
Species: dog
Canine-Specific: Yes
Tags: EFA, GLA, PGE1, linoleic_acid, ceramide-1
Summary: GLA → DGLA → PGE1 pathway documented. LA modulates ceramide-1. Omega 3-6-9 blend covers three distinct lipid pathways. Supports GLA-PGE1 and EFA membrane pathway scoring. Cross-ref N05.

N11_04

Authors: Reiter LV, Torres SM, Wertz PW.
Title: Characterization and quantification of ceramides in nonlesional skin of canine patients with AD
Journal: Vet Dermatol (2009)
ID: PMID: 19659839
URL: https://pubmed.ncbi.nlm.nih.gov/19659839/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: ceramides, direct_constituent, barrier_molecule
Summary: Ceramides are direct lamellar constituents — the actual barrier molecule. CER deficit documented in AD dogs. Supports ceramide pathway scoring. Cross-ref N01/N05.

N11_05

Authors: Popa I, Remoue N, Osta B, et al.
Title: Lipid alterations in SC of dogs with AD alleviated by sphingolipid emulsion
Journal: Clin Exp Dermatol (2012)
ID: PMID: 22188585
URL: https://pubmed.ncbi.nlm.nih.gov/22188585/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: ceramide_restoration, sphingolipid, barrier
Summary: Ceramide replacement restores SC lipid composition. Oral ceramide bioavailability = PK2 (cap below 85). Cross-ref N01/N05.

N12 — BDC Hydration Layer Pathways (3 Pathways — Canine)

Tier: C (BDC Subsystem Pathways) Citations: 4

N12_01

Authors: Balogh L, Polyak A, Mathe D, et al.
Title: Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs
Journal: J Agric Food Chem (2008)
ID: PMID: 18959406
URL: https://pubmed.ncbi.nlm.nih.gov/18959406/
Evidence Type: mechanistic
Species: dog/rat
Canine-Specific: Yes
Tags: HA, oral_bioavailability, skin, GAG_hydration
Summary: Oral HA reaches skin tissue in dogs. 13.3% retention at 72h. Supports GAG hydration pathway scoring. HA is direct tissue constituent input, not precursor. Cross-ref N06.

N12_02

Authors: Szczepanik M, Wilkolek P, Golynski M, et al.
Title: Correlation between CADESI-03 and biophysical skin measures in dogs with AD
Journal: Vet Dermatol (2015)
ID: PMID: 25852229
URL: https://pubmed.ncbi.nlm.nih.gov/25852229/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: TEWL, skin_hydration, biophysical
Summary: TEWL regulation validated as hydration biomarker. Hydration measured at multiple body sites. Supports TEWL regulation pathway scoring. Cross-ref N02/N06.

N12_03

Authors: Marsella R, Samuelson D.
Title: Unravelling the skin barrier: a new paradigm for atopic dermatitis and house dust mites
Journal: Vet Dermatol (2009)
ID: PMID: 19659837
URL: https://pubmed.ncbi.nlm.nih.gov/19659837/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: NMF, filaggrin, tight_junctions, hydration
Summary: NMF degradation products maintain SC hydration. Filaggrin-like protein deficiencies reduce NMF. Supports aquaporin modulation pathway (limited direct evidence). Cross-ref N01/N06.

N12_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: GAG, HA, dermatan_sulfate, water_retention
Summary: HA primary dermal water reservoir. Kibble 10% moisture = negligible dietary water. Lowest BDC supplemented score (58/100) — single direct hydration input. Cross-ref N01.

N13 — BDC Immune Tone Pathways (4 Pathways — Canine)

Tier: C (BDC Subsystem Pathways) Citations: 5

N13_01

Authors: Mueller RS, Fieseler KV, Fettman MJ, et al.
Title: Effect of omega-3 fatty acids on canine atopic dermatitis
Journal: J Small Anim Pract (2004)
ID: PMID: 15206474
URL: https://pubmed.ncbi.nlm.nih.gov/15206474/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: EPA, DHA, resolvin, protectin, pruritus
Summary: EPA/DHA provide direct precursors for resolvin E1, D1 and protectin D1 synthesis. RCT demonstrates anti-inflammatory benefit. Supports resolvin/protectin synthesis pathway scoring. Cross-ref N05/N07.

N13_02

Authors: Paris G, Pozza M, Anquetil H, et al.
Title: β-Glucan-induced trained immunity in dogs
Journal: Front Immunol (2020)
ID: PMC: PMC7581789
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7581789/
Evidence Type: mechanistic
Species: dog
Canine-Specific: Yes
Tags: beta-glucan, Dectin-1, trained_immunity, innate_PRR
Summary: Canine Dectin-1 receptor engagement confirmed. ~30-fold TNF-α increase. Supports innate immune PRR pathway scoring. Beta-glucan from yeast engages trained immunity. Cross-ref N07.

N13_03

Authors: Stuyven E, Cox E, Goddeeris BM, et al.
Title: Oral administration of β-1,3/1,6-glucan to dogs temporally changes total and antigen-specific IgA and IgM
Journal: Clin Vaccine Immunol (2010)
ID: PMC: PMC2815531
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC2815531/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: beta-glucan, IgA, IgM, mucosal_immunity
Summary: Oral beta-glucan modulates mucosal immunity in dogs. IgA/IgM changes documented. Supports innate immune pathway scoring. Cross-ref N07.

N13_04

Authors: Nuttall TJ, Marsella R, Rosenbaum MR, et al.
Title: Update on pathogenesis, diagnosis, and treatment of atopic dermatitis in dogs
Journal: J Am Vet Med Assoc (2019)
ID: PMID: 31380726
URL: https://pubmed.ncbi.nlm.nih.gov/31380726/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: mast_cell, IL-31, histamine, leukotriene_balance
Summary: Mast cell mediator regulation pathway. IL-31 drives pruritus via JAK pathway. Leukotriene balance modulation via 5-LOX competition documented. Capped below 75 (maintenance-level EPA/DHA dose). Cross-ref N02/N07.

N13_05

Authors: Olivry T, Marsella R, Hillier A.
Title: The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective?
Journal: Vet Immunol Immunopathol (2001)
ID: PMID: 11553397
URL: https://pubmed.ncbi.nlm.nih.gov/11553397/
Evidence Type: systematic_review
Species: dog
Canine-Specific: Yes
Tags: EFA, leukotriene, prostaglandin, immune_modulation
Summary: EFAs modulate leukotriene production — LTB5 less inflammatory than LTB4. Supports leukotriene balance pathway scoring. Cross-ref N05/N07.

N14 — BDC Repair & Turnover Pathways (5 Pathways — Canine)

Tier: C (BDC Subsystem Pathways) Citations: 5

N14_01

Authors: White SD, Bourdeau P, Rosychuk RA, et al.
Title: Zinc-responsive dermatosis in dogs: 41 cases and literature review
Journal: Vet Dermatol (2001)
ID: PMID: 11360336
URL: https://pubmed.ncbi.nlm.nih.gov/11360336/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: zinc, epidermal_proliferation, Grade_A
Summary: Chelated zinc supports epidermal proliferation (Grade A). Parakeratosis = disordered proliferation without zinc. Supports epidermal proliferation pathway scoring. Cross-ref N04/N08.

N14_02

Authors: Ihrke PJ, Goldschmidt MH.
Title: Vitamin A-responsive dermatosis in the dog
Journal: J Am Vet Med Assoc (1983)
ID: PMID: 6221006
URL: https://pubmed.ncbi.nlm.nih.gov/6221006/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: vitamin_A, follicular_cycling, retinoid
Summary: Retinoid pathway drives coat renewal. No direct supplemental vitamin A input in formulation — capped below 75. Cross-ref N08.

N14_03

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: B-vitamins, iron, mineral_matrix, cellular_metabolism
Summary: B-vitamin dependent cellular metabolism for rapid-turnover tissue. Iron for oxygen delivery. Mineral matrix for wound-healing cascade. Supports B-vitamin metabolism and mineral matrix pathways. Cross-ref N01.

N14_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: epidermal_cycling, follicular_cycling, L-carnitine, mitochondrial
Summary: L-carnitine provides mitochondrial energy for rapid-turnover epidermis (Grade C). Baseline kibble 24/100 — two pathways partially supplied at AAFCO minimums. Supplemented 69/100. Cross-ref N01.

N14_05

Authors: Frigg M, Schulze J, Volker L.
Title: Clinical study on the effect of biotin on skin conditions in dogs
Journal: Schweiz Arch Tierheilkd (1989)
ID: PMID: 2602924
URL: https://pubmed.ncbi.nlm.nih.gov/2602924/
Evidence Type: clinical_trial
Species: dog
Canine-Specific: Yes
Tags: biotin, keratinocyte, metabolic_energy, turnover
Summary: Biotin supports keratinocyte metabolic function for continuous renewal. Grade A evidence. Indirect support for B-vitamin metabolism pathway. Cross-ref N04/N08.

N15 — EPA/DHA (Fish Oil — Omega-3 Backbone, Including ALA Conversion Context)

Tier: D (Ingredient Modules) Citations: 8

N15_01

Authors: Mueller RS, Fieseler KV, Fettman MJ, et al.
Title: Effect of omega-3 fatty acids on canine atopic dermatitis
Journal: J Small Anim Pract (2004)
ID: PMID: 15206474
URL: https://pubmed.ncbi.nlm.nih.gov/15206474/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: EPA, DHA, RCT, pruritus, atopic_dermatitis, Grade_A
Summary: Landmark RCT: EPA 50mg/kg/day + DHA 35mg/kg/day. 50% of treated dogs improved ≥50%. Grade A canine evidence for omega-3 in AD. Cross-ref N05/N07.

N15_02

Authors: Olivry T, Marsella R, Hillier A.
Title: The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective?
Journal: Vet Immunol Immunopathol (2001)
ID: PMID: 11553397
URL: https://pubmed.ncbi.nlm.nih.gov/11553397/
Evidence Type: systematic_review
Species: dog
Canine-Specific: Yes
Tags: EFA, omega-3, omega-6, eicosanoid, ACVD, systematic
Summary: Systematic review of >20 EFA trials. EPA competes with AA for COX/LOX substrates. Shifts leukotriene profile from LTB4 to LTB5. Cross-ref N05.

N15_03

Authors: Logas D, Kunkle GA.
Title: Double-blinded crossover study with marine oil supplementation containing high-dose icosapentaenoic acid for the treatment of canine pruritic skin disease
Journal: Vet Dermatol (1994)
ID: PMID: 34645070
URL: https://pubmed.ncbi.nlm.nih.gov/34645070/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: marine_oil, EPA, DHA, pruritus, crossover, high_dose
Summary: Double-blind crossover: 16 dogs, high-dose EPA (180mg) + DHA (120mg) per 4.55kg. Effective anti-inflammatory for canine pruritic skin disease. Grade A.

N15_04

Authors: Hesta M, Ottermans C, Gils J, et al.
Title: Enhanced omega-3 index after long- versus short-chain omega-3 fatty acid supplementation in dogs
Journal: Vet Med Sci (2021)
ID: PMC: PMC8025612
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC8025612/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: omega-3_index, ALA_conversion, marine_vs_plant, flaxseed, krill
Summary: Marine EPA/DHA significantly increased Omega-3 Index in dogs; ALA from flaxseed did not. Confirms ALA conversion to EPA/DHA is functionally negligible in dogs. PK evidence for marine-source requirement.

N15_05

Authors: Combarros D, Castilla-Castaño E, Rosenberg D, et al.
Title: A prospective, randomized, double-blind, placebo-controlled evaluation of n-3 EFA supplement on clinical signs and FA concentrations in dogs with poor quality coats
Journal: Prostaglandins Leukot Essent Fatty Acids (2020)
URL: https://www.sciencedirect.com/science/article/pii/S0952327820300983
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: omega-3, coat_quality, erythrocyte_membrane, EPA_DHA_incorporation
Summary: 24 dogs with poor haircoat. EPA/DHA supplementation: clinical score improved from day 60. EPA and DHA incorporated into erythrocyte membrane from day 30. Grade A for coat quality improvement.

N15_06

Authors: Fritsch DA, Allen TA, Dodd CE, et al.
Title: A multicenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis
Journal: J Am Vet Med Assoc (2010)
ID: PMID: 20187817
URL: https://pubmed.ncbi.nlm.nih.gov/20187817/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: omega-3, fish_oil, anti-inflammatory, multi-system, NSAID-sparing
Summary: Fish oil omega-3 reduced NSAID requirement by 33% in OA dogs. Demonstrates multi-system anti-inflammatory benefit beyond skin. EPA/DHA = multi-system backbone nutrient.

N15_07

Authors: Mazzonetto Costa C, et al.
Title: Therapeutic effect of EPA/DHA supplementation in neoplastic and non-neoplastic companion animal diseases: a systematic review
Journal: In Vivo (2021)
ID: PMC: PMC8193331
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC8193331/
Evidence Type: systematic_review
Species: dog/cat
Canine-Specific: Yes
Tags: systematic_review, EPA, DHA, dermatitis, pruritus, companion_animal
Summary: Systematic review: 23 studies (20 dogs, 3 cats). Therapeutic benefit in canine allergic dermatitis, haircoat disorder. 6/8 dermatology studies showed significant improvement. Grade A aggregate evidence.

N15_08

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: EFA, ALA_conversion, diet, skin
Summary: ALA conversion to EPA <8% in dogs, <1% to DHA. Most kibble provides omega-3 as ALA only — functionally negligible for resolvin synthesis. Cross-ref N01.

N16 — GLA (Gamma-Linolenic Acid — Evening Primrose Oil)

Tier: D (Ingredient Modules) Citations: 6

N16_01

Authors: Olivry T, Marsella R, Hillier A.
Title: The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective?
Journal: Vet Immunol Immunopathol (2001)
ID: PMID: 11553397
URL: https://pubmed.ncbi.nlm.nih.gov/11553397/
Evidence Type: systematic_review
Species: dog
Canine-Specific: Yes
Tags: GLA, DGLA, PGE1, evening_primrose, borage, EFA
Summary: GLA → DGLA → PGE1 anti-inflammatory pathway documented. Evening primrose oil and borage oil efficacy reviewed for canine AD. GLA competes with AA in eicosanoid production. Cross-ref N05.

N16_02

Authors: Harvey RG.
Title: A blinded, placebo-controlled study comparing the efficacy of borage seed oil and fish oil in the management of canine atopy
Journal: Vet Rec (1999)
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: borage_oil, GLA, fish_oil, canine_atopy, placebo-controlled
Summary: Blinded placebo-controlled study: borage seed oil (GLA source) + fish oil. Significant reduction in erythema and self-trauma. GLA + EPA/DHA combination more effective than either alone.

N16_03

Authors: Scarff DH, Lloyd DH.
Title: Double blind, placebo-controlled, crossover study of evening primrose oil in the treatment of canine atopy
Journal: Vet Rec (1992)
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: evening_primrose_oil, GLA, canine_atopy, crossover, double-blind
Summary: Double-blind crossover: evening primrose oil (GLA source) reduced pruritus in canine atopy compared to placebo. Early canine evidence for GLA supplementation.

N16_04

Authors: Bond R, Lloyd DH.
Title: A double-blind comparison of olive oil and a combination of evening primrose oil and fish oil in the management of canine atopy
Journal: Vet Rec (1992)
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: EPO, fish_oil, GLA, canine_atopy, combination
Summary: EPO + fish oil vs olive oil control in canine atopy. Combination GLA + omega-3 therapy showed benefit. Supports synergistic GLA-EPA/DHA formulation approach.

N16_05

Authors: Saevik BK, Bergvall K, Holm BR, et al.
Title: A randomized, controlled study to evaluate the steroid sparing effect of essential fatty acid supplementation in the treatment of canine atopic dermatitis
Journal: Vet Dermatol (2004)
ID: PMID: 15030553
URL: https://pubmed.ncbi.nlm.nih.gov/15030553/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: EFA, steroid-sparing, GLA, omega-3, canine_AD
Summary: EFA supplementation (GLA + omega-3) reduced prednisolone requirement in canine AD. Steroid-sparing effect demonstrates clinical significance of GLA pathway engagement.

N16_06

Authors: Marsh KA, Ruedisueli FL, Coe SL, Watson TD.
Title: Effects of zinc and linoleic acid supplementation on skin and coat quality of dogs
Journal: Vet Dermatol (2000)
ID: PMID: 11117397
URL: https://pubmed.ncbi.nlm.nih.gov/11117397/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: linoleic_acid, omega-6, skin, coat, supplementation
Summary: Linoleic acid (GLA precursor) supplementation improved coat quality. LA → GLA conversion via delta-6-desaturase. Direct GLA supplementation bypasses rate-limiting enzyme step. Cross-ref N04.

N17 — Hydrolyzed Collagen Peptides, Gelatin & Glycine (Structural Protein Inputs)

Tier: D (Ingredient Modules) Citations: 5

N17_01

Authors: Alger SJ, et al.
Title: Oral intake of BCP improves gait in canine OA patients
Journal: Animals (Basel) (2024)
ID: PMID: 39298537
URL: https://pubmed.ncbi.nlm.nih.gov/39298537/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: collagen_peptides, BCP, canine, bioavailability, ECM
Summary: Canine BCP bioavailability demonstrated. Pro-Hyp peptide signaling stimulates ECM synthesis. 3-month supplementation efficacy. Cross-ref N03.

N17_02

Authors: Blees NR, et al.
Title: Collagen hydrolysates as nutritional support in canine osteoarthritis: a narrative review
Journal: J Anim Physiol Anim Nutr (2025)
URL: https://onlinelibrary.wiley.com/doi/10.1111/jpn.14076
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: collagen_hydrolysate, Pro-Hyp, Hyp-Gly, canine_bioavailability
Summary: Pro-Hyp and Hyp-Gly peptides reach max blood concentration 1-2h post-ingestion in dogs. Canine digestive differences noted. Cross-ref N03.

N17_03

Authors: León-López A, et al.
Title: Hydrolyzed collagen — sources and applications
Journal: Molecules (2019)
ID: PMC: PMC6891674
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6891674/
Evidence Type: review
Species: mixed
Canine-Specific: No
Tags: hydrolyzed_collagen, glycine, proline, fibroblast
Summary: Collagen = 33% glycine + 22% proline/hydroxyproline. Triple-helix. Low MW peptides most bioactive. Cross-ref N03.

N17_04

Authors: Fernandes de Melo AC, et al.
Title: Effects of hydrolyzed collagen on fibroblast activation: systematic review
Journal: Nutrients (2024)
ID: PMC: PMC11173906
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11173906/
Evidence Type: systematic_review
Species: human/in_vitro
Canine-Specific: No
Tags: collagen, fibroblast, ECM, systematic_review
Summary: Systematic review: hydrolyzed collagen stimulates fibroblast proliferation and ECM production. Translational support for collagen synthesis pathway. Cross-ref N03.

N17_05

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: protein, amino_acid, collagen, skin_demand
Summary: 25-30% dietary protein to skin/coat. Precursor availability rate-limiting at fibroblast level. Cross-ref N01.

N18 — Hyaluronic Acid (Oral HA — Dermal Hydration)

Tier: D (Ingredient Modules) Citations: 4

N18_01

Authors: Balogh L, Polyak A, Mathe D, et al.
Title: Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs
Journal: J Agric Food Chem (2008)
ID: PMID: 18959406
URL: https://pubmed.ncbi.nlm.nih.gov/18959406/
Evidence Type: mechanistic
Species: dog/rat
Canine-Specific: Yes
Tags: HA, oral_bioavailability, skin, Beagle, tissue_distribution
Summary: Key PK evidence: oral HMW-HA in Beagle dogs. 13.3% retained at 72h. Distributed to skin, joints, bone. Demonstrates canine oral HA bioavailability. Cross-ref N06.

N18_02

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: HA, GAG, dermatan_sulfate, water_retention, dermal
Summary: HA is primary hygroscopic macromolecule in dermis. Direct tissue constituent input, not precursor. GAG hydration pathway. Cross-ref N01.

N18_03

Authors: Szczepanik M, Wilkolek P, Golynski M, et al.
Title: Correlation between CADESI-03 and biophysical skin measures in dogs with AD
Journal: Vet Dermatol (2015)
ID: PMID: 25852229
URL: https://pubmed.ncbi.nlm.nih.gov/25852229/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: skin_hydration, TEWL, biophysical, CADESI
Summary: Skin hydration measured at multiple body sites. TEWL correlated with CADESI severity. Validates hydration assessment methods for canine skin. Cross-ref N02/N06.

N18_04

Authors: Marsella R, Samuelson D.
Title: Unravelling the skin barrier: NMF and hydration paradigm
Journal: Vet Dermatol (2009)
ID: PMID: 19659837
URL: https://pubmed.ncbi.nlm.nih.gov/19659837/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: NMF, filaggrin, hydration, SC_water_content
Summary: NMF degradation products maintain SC hydration. HA supports deeper dermal water retention. Oral HA bioavailability debated — absorption demonstrated but cutaneous tissue delivery remains uncertain. Cross-ref N01/N06.

N19 — Biotin (Vitamin B7 — Keratinocyte Carboxylase Cofactor)

Tier: D (Ingredient Modules) Citations: 3

N19_01

Authors: Frigg M, Schulze J, Volker L.
Title: Clinical study on the effect of biotin on skin conditions in dogs
Journal: Schweiz Arch Tierheilkd (1989)
ID: PMID: 2602924
URL: https://pubmed.ncbi.nlm.nih.gov/2602924/
Evidence Type: clinical_trial
Species: dog
Canine-Specific: Yes
Tags: biotin, keratinocyte, carboxylase, Grade_A, coat, skin
Summary: Grade A canine evidence: 119 dogs treated with biotin. Dull coat, brittle hair, alopecia, scaling, pruritus all improved. Biotin-dependent carboxylase activity essential for fatty-acid synthesis in keratinocytes. Cross-ref N04.

N19_02

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: biotin, deficiency, skin, diet
Summary: Biotin deficiency causes alopecia, crusting, seborrhea in dogs. Raw egg white (avidin) interferes with biotin absorption. Supplementation at 50mcg targets keratinocyte carboxylase pathway. Cross-ref N01.

N19_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: biotin, carboxylase, acetyl-CoA, pyruvate, propionyl-CoA
Summary: Biotin cofactor for acetyl-CoA carboxylase (fatty acid synthesis), pyruvate carboxylase, propionyl-CoA carboxylase. Keratinocyte proliferation support. Cross-ref N01.

N20 — Zinc (Chelated Forms — Multi-Pathway Metalloenzyme Cofactor)

Tier: D (Ingredient Modules) Citations: 6

N20_01

Authors: White SD, Bourdeau P, Rosychuk RA, et al.
Title: Zinc-responsive dermatosis in dogs: 41 cases and literature review
Journal: Vet Dermatol (2001)
ID: PMID: 11360336
URL: https://pubmed.ncbi.nlm.nih.gov/11360336/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: zinc, dermatosis, Siberian_Husky, parakeratosis, Grade_A
Summary: 41 cases: breed predisposition (Siberian Husky). Parakeratosis diagnostic. Grade A canine evidence for zinc-keratinocyte dependency. Cross-ref N04.

N20_02

Authors: Colombini S.
Title: Canine zinc-responsive dermatosis
Journal: Vet Clin North Am Small Anim Pract (1999)
ID: PMID: 10563006
URL: https://pubmed.ncbi.nlm.nih.gov/10563006/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: zinc, syndrome_I_II, phytate, metalloenzyme, keratinization
Summary: Two syndromes: I (breed-specific, balanced diet) and II (dietary deficiency/phytate). Zinc regulates >300 enzymes. Phytate and calcium impede absorption. Chelated forms bypass phytate. Cross-ref N04.

N20_03

Authors: Marsh KA, et al.
Title: Zinc + linoleic acid supplementation RCT
Journal: Vet Dermatol (2000)
ID: PMID: 11117397
URL: https://pubmed.ncbi.nlm.nih.gov/11117397/
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: zinc, RCT, supplementation, coat_quality, AAFCO
Summary: RCT: zinc + LA improved coat quality above AAFCO baseline in dogs on complete/balanced diets. Demonstrates supplemental benefit. Grade A. Cross-ref N04.

N20_04

Authors: Robson MC, et al.
Title: Oxidative stress in canine zinc-responsive dermatosis pathogenesis
Journal: Vet Dermatol (2010)
ID: PMID: 20723188
URL: https://pubmed.ncbi.nlm.nih.gov/20723188/
Evidence Type: mechanistic
Species: dog
Canine-Specific: Yes
Tags: zinc, oxidative_stress, metallothionein, HSP, apoptosis
Summary: Low metallothionein = low zinc = oxidative vulnerability. HSPs compensatory. Links zinc to antioxidant defense. Narrow therapeutic index — excess impairs copper absorption. Cross-ref N04.

N20_05

Authors: Linder KE, et al.
Title: Zinc-responsive dermatosis in northern-breed dogs: 17 cases
Journal: J Am Vet Med Assoc (1997)
ID: PMID: 9267507
URL: https://pubmed.ncbi.nlm.nih.gov/9267507/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: zinc, northern_breed, dosing, chelated, maintenance
Summary: 17 northern-breed dogs: response rate, optimal dose, recurrence documented. Chelated forms improve bioavailability vs oxide. Maintenance dosing recommendations. Cross-ref N04.

N20_06

Authors: Sousa CA, Stannard AA, Ihrke PJ, et al.
Title: Dermatosis from generic dog food: 13 cases
Journal: J Am Vet Med Assoc (1988)
ID: PMID: 3372335
URL: https://pubmed.ncbi.nlm.nih.gov/3372335/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: generic_food, zinc, nutrition, keratinization
Summary: Generic food induced zinc-related keratinization disorders. Resolved with diet change. Cross-ref N04.

N21 — MSM (Methylsulfonylmethane — Bioavailable Sulfur Donor)

Tier: D (Ingredient Modules) Citations: 3

N21_01

Authors: Butawan M, Benjamin RL, Bloomer RJ.
Title: Methylsulfonylmethane: applications and safety of a novel dietary supplement
Journal: Nutrients (2017)
ID: PMC: PMC5372953
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC5372953/
Evidence Type: review
Species: human/animal
Canine-Specific: No
Tags: MSM, sulfur, anti-inflammatory, NF-kB, keratin, collagen
Summary: Comprehensive review: MSM provides 34% sulfur by mass. Inhibits NF-κB, reduces IL-1β, IL-6, TNF-α. Sulfur essential for disulfide bonds in keratin and collagen. FDA GRAS status. Translational evidence (Grade C).

N21_02

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: sulfur, keratin, disulfide, cysteine, methionine
Summary: Keratin disulfide cross-links require sulfur from cysteine/methionine. MSM provides organic sulfur alternative. Limited direct canine dermatological evidence — mostly equine/human translational. Cross-ref N01.

N21_03

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: sulfur_amino_acids, methionine, cysteine, keratin, skin
Summary: Sulfur amino acid adequacy rate-limiting for coat quality. MSM provides bioavailable sulfur to supplement methionine/cysteine pathways. Cross-ref N01.

N22 — Ceramides (Oral Phytoceramides — Direct Lamellar Constituent)

Tier: D (Ingredient Modules) Citations: 4

N22_01

Authors: Reiter LV, Torres SM, Wertz PW.
Title: Characterization and quantification of ceramides in nonlesional skin of canine AD patients
Journal: Vet Dermatol (2009)
ID: PMID: 19659839
URL: https://pubmed.ncbi.nlm.nih.gov/19659839/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: ceramides, CER_EOS, CER_NP, stratum_corneum, barrier
Summary: CER[EOS], CER[EOP], CER[NP] decreased in AD dog skin. Ceramides are the actual barrier molecule — direct lamellar constituent. Grade A canine evidence for ceramide deficit. Cross-ref N01.

N22_02

Authors: Popa I, Remoue N, Osta B, et al.
Title: Lipid alterations in SC of dogs with AD alleviated by sphingolipid emulsion
Journal: Clin Exp Dermatol (2012)
ID: PMID: 22188585
URL: https://pubmed.ncbi.nlm.nih.gov/22188585/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: ceramide_restoration, sphingolipid, topical, barrier
Summary: Topical ceramide replacement restores SC lipid alterations. Demonstrates proof of concept for ceramide replenishment. Oral route bioavailability = PK2. Cross-ref N01.

N22_03

Authors: Chermprapai S, et al.
Title: Altered SC lipid properties in CAD
Journal: Biochim Biophys Acta Biomembr (2018)
ID: PMID: 29175102
URL: https://pubmed.ncbi.nlm.nih.gov/29175102/
Evidence Type: mechanistic
Species: dog
Canine-Specific: Yes
Tags: ceramide, lipid_organization, FTIR, SAXD
Summary: SC lipid organization disrupted in canine AD. Ceramide chain length ratios correlate with severity. Cross-ref N05.

N22_04

Authors: Shimada K, et al.
Title: Decreased ceramide content in AD dog skin
Journal: Vet Dermatol (2009)
ID: PMID: 19659838
URL: https://pubmed.ncbi.nlm.nih.gov/19659838/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: ceramides, TEWL, barrier_dysfunction
Summary: Free ceramide content decreased in both lesional and non-lesional AD skin. Ceramide deficit = intrinsic barrier defect. 8mg ceramides at maintenance dose. Cross-ref N01.

N23 — Omega-7 / Palmitoleic Acid (Epithelial Lipid Support)

Tier: D (Ingredient Modules) Citations: 3

N23_01

Authors: Guo X, Yang B, Kallio H, et al.
Title: The impact of sea buckthorn oil fatty acids on human health
Journal: Lipids Health Dis (2019)
ID: PMC: PMC6589177
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6589177/
Evidence Type: review
Species: human
Canine-Specific: No
Tags: palmitoleic_acid, sea_buckthorn, omega-7, epithelial, mucosal, skin
Summary: Sea buckthorn pulp oil: 36-48% palmitoleic acid. Fosters cutaneous and mucosal epithelialization. Anti-inflammatory signaling (lipokine). Translational evidence (Grade C) — no canine-specific skin studies.

N23_02

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: EFA, lipid, skin, epithelial
Summary: Dietary fatty acid composition affects epithelial membrane composition. Omega-7 at 50mg provides epithelial lipid support pathway — limited direct canine evidence. Cross-ref N01.

N23_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: epithelial, lipid, mucosal, skin_membrane
Summary: Epithelial lipid composition affected by dietary fatty acid profile. Palmitoleic acid targets epithelial-specific lipid composition. Evidence gap: no canine dermatology PubMed studies. Cross-ref N01.

N24 — Vitamin E (Mixed Tocopherols — Lipid-Phase Antioxidant)

Tier: D (Ingredient Modules) Citations: 4

N24_01

Authors: Plevnik Kapun A, Salobir J, Levart A, et al.
Title: Vitamin E supplementation in canine atopic dermatitis: improvement of clinical signs and effects on oxidative stress markers
Journal: Vet Rec (2014)
URL: https://bvajournals.onlinelibrary.wiley.com/doi/10.1136/vr.102547
Evidence Type: RCT
Species: dog
Canine-Specific: Yes
Tags: vitamin_E, atopic_dermatitis, CADESI, oxidative_stress, malondialdehyde, antioxidant
Summary: RCT: 29 dogs with CAD. Vitamin E 8.1 IU/kg/day for 8 weeks. Measured CADESI-03, pruritus, MDA, TAC, GPx, SOD, plasma/skin vitamin E. Demonstrates vitamin E antioxidant function in canine AD skin.

N24_02

Authors: Plevnik Kapun A, Salobir J, Levart A, et al.
Title: Plasma and skin vitamin E concentrations in canine atopic dermatitis
Journal: Vet Dermatol (2013)
ID: PMID: 23323961
URL: https://pubmed.ncbi.nlm.nih.gov/23323961/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: vitamin_E, plasma, skin, atopic_dermatitis, concentration
Summary: Low plasma vitamin E in CAD dogs. Serum vitamin E correlates with skin vitamin E levels. Supplementation increases both plasma and skin concentrations.

N24_03

Authors: Jewell DE, et al.
Title: Effect of dietary antioxidants on free radical damage in dogs and cats
Journal: J Anim Sci (2024)
ID: PMC: PMC11185959
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11185959/
Evidence Type: clinical
Species: dog/cat
Canine-Specific: Yes
Tags: vitamin_E, antioxidant, lipid_peroxidation, alkenal, immune
Summary: Vitamin E at 445-540 IU/kg food decreased serum alkenal (lipid peroxidation marker) in dogs and cats. Enhanced immune cell protection. Reduced DNA damage.

N24_04

Authors: Marsella R, Olivry T, Carlotti DN.
Title: Current evidence of skin barrier dysfunction in human and canine atopic dermatitis
Journal: Vet Dermatol (2011)
ID: PMID: 21649737
URL: https://pubmed.ncbi.nlm.nih.gov/21649737/
Evidence Type: review
Species: dog/human
Canine-Specific: Yes
Tags: barrier, oxidative_stress, lipid_peroxidation, membrane
Summary: Lipid peroxidation damages SC membrane integrity. Vitamin E as chain-breaking antioxidant terminates lipid peroxidation. Multi-compartment strategy: vitamin E (lipid) + vitamin C (aqueous). Cross-ref N01.

N25 — Vitamin C (Ascorbic Acid — Prolyl Hydroxylase Cofactor & Aqueous Antioxidant)

Tier: D (Ingredient Modules) Citations: 3

N25_01

Authors: Murad S, Grove D, Lindberg KA, et al.
Title: Regulation of collagen synthesis by ascorbic acid
Journal: Proc Natl Acad Sci USA (1981)
ID: PMID: 6265920
URL: https://pubmed.ncbi.nlm.nih.gov/6265920/
Evidence Type: mechanistic
Species: human/in_vitro
Canine-Specific: No
Tags: vitamin_C, collagen, prolyl_hydroxylase, lysyl_hydroxylase, fibroblast
Summary: Ascorbic acid essential cofactor for prolyl and lysyl hydroxylase. Stimulates collagen-specific mRNA ~8-fold. Beyond hydroxylation: direct transcriptional regulation of collagen gene expression. Translational evidence.

N25_02

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: vitamin_C, endogenous_synthesis, collagen, antioxidant
Summary: Dogs synthesize vitamin C endogenously (unlike humans). ~40mg/kg/day hepatic synthesis. Supplementation may benefit dogs under oxidative stress or high collagen demand. Cross-ref N01.

N25_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: vitamin_C, collagen_cross-linking, aqueous_antioxidant, vitamin_E_regeneration
Summary: Vitamin C regenerates oxidized vitamin E — aqueous-phase complement to lipid-phase antioxidant. Collagen maturation requires vitamin C for proline/lysine hydroxylation. Cross-ref N01.

N26 — ⊘ Selenium — NOT in LPL-01 Formulation — Comparative GPx/Antioxidant Context

Tier: D (Ingredient Modules) Citations: 4

⊘ Formulation status: Selenium is NOT in Hollywood Elixir or Pet Gala. It is documented here as comparative context because selenium-dependent GPx enzymes are the primary enzymatic defense against lipid hydroperoxides — directly relevant to the Lipid Barrier and Immune Tone subsystems. The selenoprotein pathway is addressed in LPL-01 via Zinc/Cu-Zn-SOD (PG) and Glutathione (HE) via complementary but non-identical mechanisms.

Where this fits: ⊘ Not in LPL-01 formulation. Cross-reference to Zinc (PG — chelated 1.5mg) and Glutathione (HE — 50mg) as the in-formulation antioxidant/redox-defense alternatives that address the same Lipid Barrier and Immune Tone pathways selenium is classically tied to.

N26_01

Authors: Pilarczyk B, Tomza-Marciniak A, Pilarczyk R, et al.
Title: Selenium and dogs: a systematic review
Journal: Animals (Basel) (2021)
ID: PMC: PMC7915357
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7915357/
Evidence Type: systematic_review
Species: dog
Canine-Specific: Yes
Tags: selenium, systematic_review, GPx, selenoprotein, canine
Summary: ⊘ [Selenium not in LPL-01 — comparative context only] Systematic review: selenium in canine nutrition. GPx activity as biomarker. Narrow window between deficiency and excess. Carnivores preserve higher Se levels. No naturally occurring canine poisoning described.

N26_02

Authors: Van Zelst M, Hesta M, Gray K, et al.
Title: Biomarkers of selenium status in dogs
Journal: BMC Vet Res (2016)
ID: PMC: PMC4717652
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC4717652/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: selenium, biomarker, GPx, serum, selenoprotein, Beagle
Summary: ⊘ [Selenium not in LPL-01 — comparative context only] Low Se diet in dogs: serum Se and GPx significantly decreased. Selenoprotein gene expression (GPx1, SelH, SepW1, TrxRd1/2) measured. Se status monitoring validated in dogs.

N26_03

Authors: Jewell DE, et al.
Title: Effect of dietary antioxidants on free radical damage in dogs and cats
Journal: J Anim Sci (2024)
ID: PMC: PMC11185959
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11185959/
Evidence Type: clinical
Species: dog/cat
Canine-Specific: Yes
Tags: selenium, antioxidant, free_radical, vitamin_E, synergy
Summary: ⊘ [Selenium not in LPL-01 — comparative context only; Vitamin E 15 IU IS in HE] Dietary antioxidant supplementation (including selenium) decreased free radical damage markers in dogs and cats. Selenium + vitamin E synergistic. Cross-ref N24.

N26_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: selenium, GPx, thioredoxin_reductase, immune, narrow_window
Summary: ⊘ [Selenium not in LPL-01 — comparative context only] Selenium cofactor for GPx family and thioredoxin reductase. Immune cell redox regulation. Narrow therapeutic window — toxicity possible at high doses. Exudative diathesis in deficiency. Cross-ref N01.

N27 — Astaxanthin (Membrane-Spanning Antioxidant — UV & Oxidative Defense)

Tier: D (Ingredient Modules) Citations: 3

N27_01

Authors: Park JS, Chyun JH, Kim YK, et al.
Title: Astaxanthin uptake in domestic dogs and cats
Journal: Nutr Metab (Lond) (2010)
ID: PMC: PMC2898833
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC2898833/
Evidence Type: clinical
Species: dog/cat
Canine-Specific: Yes
Tags: astaxanthin, uptake, plasma, lipoprotein, leukocyte, Beagle
Summary: Astaxanthin uptake in Beagle dogs: absorbed into plasma, lipoproteins, and leukocytes. Demonstrates canine oral bioavailability (PK1). Dose-dependent plasma accumulation.

N27_02

Authors: Mancuso C, et al.
Title: Effects of astaxanthin supplementation in healthy and obese dogs
Journal: Vet Med Res Rep (2019)
ID: PMC: PMC6385744
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6385744/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: astaxanthin, oxidative_stress, NF-kB, CRP, 8-OHdG, obese
Summary: Astaxanthin in healthy and obese dogs. Reduced CRP and 8-OHdG (oxidative damage marker). NF-κB pathway suppression documented. Membrane-spanning protection.

N27_03

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: antioxidant, skin, oxidative_stress, carotenoid
Summary: Oxidative stress accelerates skin aging and barrier degradation. Multi-compartment antioxidant strategy. Astaxanthin provides membrane-spanning protection unique among carotenoids. Cross-ref N01.

N28 — Quercetin (Mast-Cell Stabilization — Canine Dermatology)

Tier: D (Ingredient Modules) Citations: 4

N28_01

Authors: Kunkel SL, Chensue SW, Phan SH.
Title: Effect of inhibitors on histamine release from mast cells recovered by bronchoalveolar lavage in basenji-greyhound and mongrel dogs
Journal: Agents Actions (1991)
ID: PMID: 1707583
URL: https://pubmed.ncbi.nlm.nih.gov/1707583/
Evidence Type: mechanistic
Species: dog
Canine-Specific: Yes
Tags: quercetin, mast_cell, histamine, canine, Basenji, inhibitor
Summary: Quercetin (10⁻⁴ M) inhibited histamine release from canine mast cells in both Basenji-Greyhound and mongrel dogs. Direct canine evidence for mast cell stabilization.

N28_02

Authors: Cerquetella M, et al.
Title: Non-controlled, open-label clinical trial to assess the effectiveness of a dietetic food on pruritus and dermatologic scoring in atopic dogs
Journal: BMC Vet Res (2019)
ID: PMC: PMC6599232
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6599232/
Evidence Type: clinical_trial
Species: dog
Canine-Specific: Yes
Tags: quercetin, polyphenol, atopic_dermatitis, pruritus, diet, mast_cell
Summary: Clinical trial: quercetin-containing dietetic food in atopic dogs. Antioxidant blend + polyphenols (quercetin) to stabilize mast cells + PUFAs. Improved skin barrier function and reduced inflammation.

N28_03

Authors: Weng Z, Zhang B, Asadi S, et al.
Title: Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans
Journal: PLoS ONE (2012)
URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0033805
Evidence Type: clinical
Species: human
Canine-Specific: No
Tags: quercetin, mast_cell, NF-kB, cromolyn, cytokine, histamine
Summary: Quercetin more effective than cromolyn (standard mast cell stabilizer) in inhibiting IL-8, TNF release. Inhibits NF-κB nuclear translocation. Translational evidence (Grade C) for canine mast cell pathway.

N28_04

Authors: Nuttall TJ, et al.
Title: Update on pathogenesis, diagnosis, and treatment of atopic dermatitis in dogs
Journal: J Am Vet Med Assoc (2019)
ID: PMID: 31380726
URL: https://pubmed.ncbi.nlm.nih.gov/31380726/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: mast_cell, histamine, IL-31, pruritus, canine_AD
Summary: Mast cell degranulation and histamine release central to canine AD pruritus. Quercetin targets this pathway. IL-31 mediated itch pathways. Cross-ref N02/N07.

N29 — ⊘ Vitamin A (Retinol/Beta-Carotene) — NOT in LPL-01 Formulation — Comparative Keratinocyte Regulation Context

Tier: D (Ingredient Modules) Citations: 4

⊘ Formulation status: Vitamin A (retinol and beta-carotene precursor) is NOT in Hollywood Elixir or Pet Gala. It is documented here as comparative context because retinoic acid is a master regulator of keratinocyte differentiation and sebaceous gland function. Keratinocyte regulation in LPL-01 is addressed via Biotin (PG — Grade [A] canine keratin integrity data), Vitamin E (HE — membrane protection in keratinocytes), and Zinc (PG — epithelial cell cycle cofactor).

Where this fits: ⊘ Not in LPL-01 formulation. Cross-reference to Biotin 50mcg (PG), Vitamin E 15 IU (HE) and Zinc 1.5mg chelated (PG) as the in-formulation actives that address Keratin Architecture and Repair & Turnover subsystems — the pathways classically attributed to retinoid signaling.

N29_01

Authors: Ihrke PJ, Goldschmidt MH.
Title: Vitamin A-responsive dermatosis in the dog
Journal: J Am Vet Med Assoc (1983)
ID: PMID: 6221006
URL: https://pubmed.ncbi.nlm.nih.gov/6221006/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: vitamin_A, retinoid, keratinization, VARD, follicular
Summary: ⊘ [Vitamin A not in LPL-01 — comparative context only] First description of VARD: 3 dogs with seborrheic dermatitis responded to oral vitamin A. Normal serum levels — utilization defect. Grade A canine evidence for retinoid pathway. Cross-ref N08.

N29_02

Authors: Lam AT, et al.
Title: Oral vitamin A for canine sebaceous adenitis
Journal: Vet Dermatol (2011)
ID: PMID: 21599767
URL: https://pubmed.ncbi.nlm.nih.gov/21599767/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: vitamin_A, sebaceous_adenitis, dosing, retinoid_pathway
Summary: ⊘ [Vitamin A not in LPL-01 — comparative context only] 40 dogs with sebaceous adenitis, 24 treated with vitamin A. Demonstrates retinoid role in follicular cycling and sebaceous function. Fat-soluble — accumulation risk. Cross-ref N08.

N29_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: vitamin_A, retinol, beta-carotene, toxicity, follicular_cycling
Summary: ⊘ [Vitamin A not in LPL-01 — comparative context only] Dogs convert beta-carotene to retinol (unlike cats). Vitamin A toxicity causes paradoxical skin/hair loss. Excess inhibits keratinization. Fat-soluble accumulation risk. Cross-ref N01.

N29_04

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: vitamin_A, skin, coat, diet, differentiation
Summary: ⊘ [Vitamin A not in LPL-01 — comparative context only] Vitamin A regulates keratinocyte proliferation and differentiation. Essential for coat renewal. Dogs require dietary vitamin A. Cross-ref N01.

N30 — B-Vitamins, Iron & L-Carnitine (Cellular Metabolism & Energy for Rapid-Turnover Tissue)

Tier: D (Ingredient Modules) Citations: 3

N30_01

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: B-vitamins, iron, L-carnitine, skin, metabolism, energy
Summary: B-vitamin complex supports cellular metabolism in rapid-turnover tissue. Iron for oxygen delivery to metabolically active epidermis. Nutritional deficiency slows repair/turnover. Cross-ref N01.

N30_02

Authors: Frigg M, et al.
Title: Biotin on skin conditions in dogs
Journal: Schweiz Arch Tierheilkd (1989)
ID: PMID: 2602924
URL: https://pubmed.ncbi.nlm.nih.gov/2602924/
Evidence Type: clinical_trial
Species: dog
Canine-Specific: Yes
Tags: biotin, B-vitamin, keratinocyte, metabolism
Summary: Biotin (B7) as example of B-vitamin with Grade A canine evidence for skin/coat. B-vitamin complex supports multiple enzymatic pathways in skin renewal. Cross-ref N04.

N30_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: iron, hemoglobin, oxygen, L-carnitine, mitochondrial, mineral_matrix
Summary: Iron-hemoglobin oxygen delivery to cutaneous tissue. L-carnitine mitochondrial beta-oxidation shuttle for energy supply (Grade C). Bone broth mineral matrix (Ca, P, Mg) for wound healing. Cross-ref N01.

N31 — Beta-Glucans 50mg (LPL-01 Active: HE) — Innate Immune Tone Calibration

Tier: D (Ingredient Modules) Citations: 4

Formulation status: Beta Glucans (50mg/sachet) are in Hollywood Elixir. They are NOT derived from yeast extract — no yeast extract is present in any LPL-01 product. Beta-glucans in HE are a dedicated ingredient providing Dectin-1/TLR-4-mediated innate immune training. The B-vitamins present in LPL-01 (Riboflavin/B2 0.5mg, Niacin/B3 2mg, B6 1mg, B12 0.25mg — all HE actives) are formulated as dedicated B-vitamin inputs and are not supplied via yeast extract.

Where this fits: HE active — Immune Tone subsystem. Cross-links to N07 (Immune Tone — Resolvins, Antioxidant Defense, IL-31, Mast Cells) and N13 (BDC Immune Tone Pathways). Note: individual cited studies below (e.g., N31_03) describe yeast-derived β-glucan preparations in their primary literature — this reflects the source material in those published trials, not the LPL-01 ingredient source.

N31_01

Authors: Paris G, Pozza M, Anquetil H, et al.
Title: β-Glucan-induced trained immunity in dogs
Journal: Front Immunol (2020)
ID: PMC: PMC7581789
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC7581789/
Evidence Type: mechanistic
Species: dog
Canine-Specific: Yes
Tags: beta-glucan, trained_immunity, Dectin-1, TNF-alpha, canine
Summary: First trained immunity demonstration in dogs. β-glucan via Dectin-1 receptor. ~30-fold TNF-α increase in canine monocytes. Immune priming without pro-inflammatory activation. Cross-ref N07.

N31_02

Authors: Stuyven E, et al.
Title: Oral β-1,3/1,6-glucan changes IgA/IgM in dogs
Journal: Clin Vaccine Immunol (2010)
ID: PMC: PMC2815531
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC2815531/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: beta-glucan, oral, IgA, IgM, Saccharomyces, Beagle
Summary: 15 Beagles, oral β-glucan 4 weeks. IgA/IgM modulation. Antigen-specific immunoglobulin changes. Effects reversed after cessation. Cross-ref N07.

N31_03

Authors: Sterckel S, et al.
Title: Dietary yeast beta-1,3/1,6-glucan supplemented to adult Labrador Retrievers alters peripheral blood immune cell responses
Journal: J Anim Sci (2023)
ID: PMC: PMC9982357
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC9982357/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: beta-glucan, vaccination, Labrador, immune_response, kibble
Summary: 24 adult Labradors. β-glucan in kibble improved immune responsiveness without sustained inflammation. Supports immune modulation pathway in dogs.

N31_04

Authors: Santoro D, et al.
Title: Pathogenesis of canine AD: skin barrier and host-micro-organism interaction
Journal: Vet Dermatol (2015)
ID: PMID: 26332445
URL: https://pubmed.ncbi.nlm.nih.gov/26332445/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: innate_immunity, antimicrobial_peptides, microbiome, immune_calibration
Summary: Innate immune pattern recognition in canine skin. β-defensins, cathelicidins. Beta-glucan engages same innate PRR system. Cross-ref N01/N07.

N32 — Copper & Silica (Collagen Cross-Linking Cofactors)

Tier: D (Ingredient Modules) Citations: 3

N32_01

Authors: Rucker RB, Kosonen T, Clegg MS, et al.
Title: Copper, lysyl oxidase, and extracellular matrix protein cross-linking
Journal: Am J Clin Nutr (1998)
ID: PMID: 9587142
URL: https://pubmed.ncbi.nlm.nih.gov/9587142/
Evidence Type: review
Species: mixed
Canine-Specific: No
Tags: copper, lysyl_oxidase, collagen, elastin, cross-linking
Summary: Lysyl oxidase = cuproenzyme essential for collagen/elastin cross-linking. Copper availability directly controls enzymatic activity. Fundamental pathway supporting collagen cross-linking scoring. Cross-ref N09.

N32_02

Authors: Colombini S.
Title: Canine zinc-responsive dermatosis
Journal: Vet Clin North Am Small Anim Pract (1999)
ID: PMID: 10563006
URL: https://pubmed.ncbi.nlm.nih.gov/10563006/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: zinc, copper, antagonism, absorption, phytate
Summary: Excess zinc impairs copper absorption via metallothionein induction. Zinc-copper balance required. Copper-responsive dermatosis documented in dogs. Cross-ref N04.

N32_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: copper, silica, collagen, elastin, ceruloplasmin
Summary: Copper cofactor for lysyl oxidase. Silica supports collagen matrix (10mg in formulation, Grade C). Copper proteinate 2.3× absorption vs sulfate form in dogs. Cross-ref N01.

N33 — Whey Protein & Sulfur Amino Acids (High-BV Keratin Precursors)

Tier: D (Ingredient Modules) Citations: 3

N33_01

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: protein, methionine, cysteine, keratin, skin_coat_demand
Summary: 25-30% dietary protein to skin/coat. Methionine → cysteine transsulfuration pathway. Sulfur amino acid adequacy rate-limiting for keratin quality. Cross-ref N01.

N33_02

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: whey, biological_value, amino_acid, keratin, disulfide
Summary: Whey protein BV ~104 — highest biological value. Cysteine incorporation into keratin disulfide bonds. High-quality amino acid supply for skin/coat. Cross-ref N01.

N33_03

Authors: Frigg M, et al.
Title: Biotin on skin conditions in dogs
Journal: Schweiz Arch Tierheilkd (1989)
ID: PMID: 2602924
URL: https://pubmed.ncbi.nlm.nih.gov/2602924/
Evidence Type: clinical_trial
Species: dog
Canine-Specific: Yes
Tags: keratin, amino_acid, coat_quality
Summary: Coat quality improvement with nutritional supplementation. Protein quality and amino acid profile affect keratin synthesis. Cross-ref N04.

N34 — BDC Scoring Methodology (Canine Integumentary — Composite 81/100 practical / 84/100 Pampered system)

Tier: E (Cross-cutting & Methodology) Citations: 4

Corrected BDC scores (canine integumentary):

Tier 1 — Kibble baseline: ~32/100
Tier 2 — PG alone: 65 raw → 81/100 practical (curved within category ceiling; 65 raw / 80 applicable ceiling)
Tier 3 — Pampered system (HE + PG): 84/100 practical (curved vs. theoretical maximum)

The composite score for the Pet Gala standalone product is 81/100 practical (65 raw, curved within the applicable category ceiling of 80). The composite for the full Pampered system (Hollywood Elixir + Pet Gala) is 84/100 practical, curved against the theoretical maximum. Any prior reference to a "70/100" composite is superseded by these values. The three-tier structure (Kibble baseline → PG alone → Pampered) preserves the A/B/C evidence grade × PK1/PK2/PK3 modifier methodology described in the citations below; only the final composite score numbers are updated.

N34_01

Authors: Olivry T, Foster AP, Mueller RS, et al.
Title: Interventions for atopic dermatitis in dogs: a systematic review of RCTs
Journal: Vet Dermatol (2010)
ID: PMID: 20141632
URL: https://pubmed.ncbi.nlm.nih.gov/20141632/
Evidence Type: systematic_review
Species: dog
Canine-Specific: Yes
Tags: systematic_review, RCT, evidence_hierarchy, Grade_A
Summary: Systematic review establishes evidence hierarchy for canine dermatology interventions. Grade A = controlled canine RCTs. Defines quality standards for BDC evidence ceiling weighting. Cross-ref N02.

N34_02

Authors: Block G, et al.
Title: Evidence-based veterinary medicine — potential, practice, and pitfalls
Journal: J Vet Intern Med (2024)
ID: PMC: PMC11586582
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11586582/
Evidence Type: review
Species: mixed
Canine-Specific: No
Tags: EBVM, evidence_pyramid, methodology, veterinary
Summary: EBVM framework: systematic reviews > RCTs > cohort > case series > expert opinion. Maps to A/B/C grading and PK1/PK2/PK3 modifier system. Cross-ref N02.

N34_03

Authors: Olivry T, Saridomichelakis M, et al.
Title: Validation of CADESI-4
Journal: Vet Dermatol (2014)
ID: PMID: 24461108
URL: https://pubmed.ncbi.nlm.nih.gov/24461108/
Evidence Type: clinical_validation
Species: dog
Canine-Specific: Yes
Tags: CADESI-04, validation, clinical_trials, scoring
Summary: CADESI-04 validated as standardized outcome measure. BDC scoring methodology depends on validated clinical endpoints. Cross-ref N02.

N34_04

Authors: Szczepanik M, et al.
Title: CADESI-03 vs biophysical measures
Journal: Vet Dermatol (2015)
ID: PMID: 25852229
URL: https://pubmed.ncbi.nlm.nih.gov/25852229/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: TEWL, CADESI, biophysical, scoring
Summary: TEWL-CADESI correlations at multiple body sites. Validates biophysical measures as BDC pathway scoring inputs. Cross-ref N02.

N35 — Formulation Crosswalk & Multi-Cascade Architecture (Canine Integumentary)

Tier: E (Cross-cutting & Methodology) Citations: 4

N35_01

Authors: Marsella R, Olivry T, Carlotti DN.
Title: Skin barrier dysfunction in human and canine atopic dermatitis
Journal: Vet Dermatol (2011)
ID: PMID: 21649737
URL: https://pubmed.ncbi.nlm.nih.gov/21649737/
Evidence Type: review
Species: dog/human
Canine-Specific: Yes
Tags: barrier, cascade, lipid_depletion, immune_activation
Summary: Cascade 1: lipid depletion → barrier breach → immune activation. Barrier-immune axis documented. Multi-point nutritional input required to interrupt cascades. Cross-ref N01.

N35_02

Authors: Nuttall TJ, et al.
Title: Update on pathogenesis of canine AD
Journal: J Am Vet Med Assoc (2019)
ID: PMID: 31380726
URL: https://pubmed.ncbi.nlm.nih.gov/31380726/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: pathogenesis, cascade, IL-31, itch-scratch, multi-system
Summary: Itch-scratch-barrier damage cascade. IL-31 mediated pruritus amplifies barrier damage. Multi-pillar formulation logic mirrors integrated barrier biology. Cross-ref N02.

N35_03

Authors: Santoro D, et al.
Title: Pathogenesis of canine AD: barrier and host-microorganism interaction
Journal: Vet Dermatol (2015)
ID: PMID: 26332445
URL: https://pubmed.ncbi.nlm.nih.gov/26332445/
Evidence Type: review
Species: dog
Canine-Specific: Yes
Tags: pathogenesis, microbiome, barrier, cascade, antimicrobial
Summary: Cascade 2: structural decline → slow repair → compounding damage. Microbiome-barrier interactions. Multi-system architecture requirement. Cross-ref N01.

N35_04

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Canine-Specific: Yes
Tags: diet, multi-nutrient, skin, cascade, formulation
Summary: Cascade 3: oxidative stress → accelerated aging → barrier degradation. Dietary intervention across multiple pathways. Six-pillar formulation logic. Cross-ref N01.

N36 — Boundary Statements (Nutrition vs Veterinary Dermatology — Canine)

Tier: E (Cross-cutting & Methodology) Citations: 3

N36_01

Authors: Olivry T, DeBoer DJ, Favrot C, et al.
Title: Treatment of canine atopic dermatitis: 2015 ICADA guidelines
Journal: BMC Vet Res (2015)
ID: PMID: 26399886
URL: https://pubmed.ncbi.nlm.nih.gov/26399886/
Evidence Type: guideline
Species: dog
Canine-Specific: Yes
Tags: treatment, guidelines, pharmacotherapy, boundary, adjunctive
Summary: ICADA guidelines: pharmacotherapy (oclacitinib, lokivetmab, cyclosporine) primary for AD. EFA supplementation adjunctive only. Supplements complement, not replace, veterinary care. Cross-ref N01.

N36_02

Authors: Hensel P, et al.
Title: Canine atopic dermatitis: diagnostic guidelines
Journal: BMC Vet Res (2015)
ID: PMID: 26276462
URL: https://pubmed.ncbi.nlm.nih.gov/26276462/
Evidence Type: guideline
Species: dog
Canine-Specific: Yes
Tags: diagnosis, ectoparasites, food_allergy, boundary
Summary: Differential diagnosis: ectoparasites, food allergy, bacterial pyoderma, endocrine disease require veterinary intervention. Supplements cannot treat these conditions. Cross-ref N01.

N36_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: boundary, pemphigus, lupus, hypothyroidism, Cushings
Summary: Immune-mediated disease (pemphigus, lupus), endocrine disease (hypothyroidism, Cushing's) require specific veterinary therapy. Age-related coat decline is primary independent nutritional domain.

N37 — Safety, Dosing Guardrails & Comfortspan Concept

Tier: E (Cross-cutting & Methodology) Citations: 4

N37_01

Authors: Olivry T, Marsella R, Hillier A.
Title: ACVD task force EFA — are essential fatty acids effective?
Journal: Vet Immunol Immunopathol (2001)
ID: PMID: 11553397
URL: https://pubmed.ncbi.nlm.nih.gov/11553397/
Evidence Type: systematic_review
Species: dog
Canine-Specific: Yes
Tags: EFA, safety, omega-3, ratio, wound_healing
Summary: Omega-3:omega-6 ratio matters — excessive omega-3 impairs wound healing. High-dose omega-3 may affect platelet function. Dosing guardrails documented. Cross-ref N05.

N37_02

Authors: Linder KE, et al.
Title: Zinc-responsive dermatosis in northern-breed dogs
Journal: J Am Vet Med Assoc (1997)
ID: PMID: 9267507
URL: https://pubmed.ncbi.nlm.nih.gov/9267507/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: zinc, narrow_therapeutic_index, copper_absorption, dosing
Summary: Zinc narrow therapeutic index. Excess impairs copper absorption. Maintenance dosing recommendations established. Cross-ref N04.

N37_03

Authors: Lam AT, et al.
Title: Oral vitamin A for canine sebaceous adenitis
Journal: Vet Dermatol (2011)
ID: PMID: 21599767
URL: https://pubmed.ncbi.nlm.nih.gov/21599767/
Evidence Type: clinical
Species: dog
Canine-Specific: Yes
Tags: vitamin_A, fat-soluble, toxicity, accumulation, dosing
Summary: Fat-soluble vitamins accumulate. Vitamin A toxicity documented at high doses. Multi-supplement stacking risks. 6-12 weeks for meaningful changes. Cross-ref N08.

N37_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Canine-Specific: Yes
Tags: safety, fat-soluble, accumulation, comfortspan
Summary: Fat-soluble vitamins (A, D, E, K) accumulate — excess not readily excreted. Comfortspan concept: duration of comfortable integumentary health. Cross-ref N01.

N38 — Canine Integumentary Evidence Gaps & Translational Uncertainty

Tier: E (Cross-cutting & Methodology) Citations: 5

N38_01

Authors: Balogh L, et al.
Title: Oral HA absorption in dogs
Journal: J Agric Food Chem (2008)
ID: PMID: 18959406
URL: https://pubmed.ncbi.nlm.nih.gov/18959406/
Evidence Type: mechanistic
Species: dog/rat
Canine-Specific: Yes
Tags: HA, oral_bioavailability, evidence_gap, skin_delivery
Summary: Oral HA reaches skin tissue, but no canine RCT measures skin hydration outcomes specifically. Cutaneous tissue delivery uncertain. Key evidence gap. Cross-ref N06.

N38_02

Authors: Guo X, et al.
Title: Sea buckthorn oil fatty acids and human health
Journal: Lipids Health Dis (2019)
ID: PMC: PMC6589177
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6589177/
Evidence Type: review
Species: human
Canine-Specific: No
Tags: omega-7, evidence_gap, translational, canine
Summary: Omega-7 canine dermatological evidence very limited. Translational from human mucosal/epithelial studies. No canine skin-specific PubMed studies identified. Grade C. Cross-ref N23.

N38_03

Authors: Butawan M, et al.
Title: MSM: applications and safety
Journal: Nutrients (2017)
ID: PMC: PMC5372953
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC5372953/
Evidence Type: review
Species: human/animal
Canine-Specific: No
Tags: MSM, evidence_gap, translational, equine
Summary: MSM canine dermatological evidence limited. Mostly equine and human translational. Anti-inflammatory properties documented but no canine skin RCT. Grade C. Cross-ref N21.

N38_04

Authors: Weng Z, et al.
Title: Quercetin vs cromolyn on mast cells
Journal: PLoS ONE (2012)
URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0033805
Evidence Type: clinical
Species: human
Canine-Specific: No
Tags: quercetin, evidence_gap, human, in_vitro
Summary: Quercetin mast cell stabilization — primarily human/in vitro evidence. One canine mast cell study (Kunkel 1991) exists but limited scope. Cross-ref N28.

N38_05

Authors: Olivry T, Foster AP, Mueller RS, et al.
Title: Interventions for AD in dogs: systematic review of RCTs
Journal: Vet Dermatol (2010)
ID: PMID: 20141632
URL: https://pubmed.ncbi.nlm.nih.gov/20141632/
Evidence Type: systematic_review
Species: dog
Canine-Specific: Yes
Tags: evidence_gap, multi-ingredient, RCT, methodology
Summary: Controlled canine RCTs evaluating multi-ingredient supplements remain limited. Most evidence is single-ingredient. Many pathway assignments rely on translational evidence. Cross-ref N02.

Summary Statistics

Metric	Value
Total nodes	38
Total citations (with cross-refs)	190
Unique citations (deduplicated)	96
Canine-specific citations	174
Human/translational citations	16
Canine-specific ratio	91.6%
RCT/Clinical	80
Review/Systematic/Guideline	74
Mechanistic/Reference	36
Tier A (Framework Foundations)	2 nodes, 18 citations
Tier B (Barrier Subsystems)	6 nodes, 45 citations
Tier C (BDC Subsystem Pathways)	6 nodes, 30 citations
Tier D (Ingredient Modules)	19 nodes, 77 citations
Tier E (Cross-cutting & Methodology)	5 nodes, 20 citations